The U.S. Environmental Protection Agency Particulate Matter Health Effects Research Centers Program: a midcourse report of status, progress, and plans. by Lippmann, Morton et al.
Over the past 15 years, an ever-increasing
number of epidemiologic studies have shown
signiﬁcant associations between the mass con-
centration of ambient air particulate matter
(PM) and adverse respiratory and cardiovascu-
lar health effects. These effects include PM
concentration-related excess rates of daily and
annual mortality, hospital admissions, emer-
gency room and clinician visits for respiratory
and cardiac diseases, increased use of medica-
tions, and time lost from work and school. By
the mid-1990s, the evidence for these associa-
tions was sufﬁciently compelling for the U.S.
Environmental Protection Agency (U.S. EPA)
to propose revised and more stringent
National Ambient Air Quality Standards
(NAAQS) for PM (NAAQS 1997). Their
form and stringency were endorsed by the U.S.
EPA Clean Air Scientiﬁc Advisory Committee
(CASAC), a group of external scientiﬁc advi-
sors whose charter was established by the
Clean Air Act Amendments of 1977 (1991).
The revised PM NAAQS, promulgated in
July 1997, retained with minor modiﬁcation
the previous daily maxima and annual average
PM NAAQS for PM whose aerodynamic
diameters were < 10 µm (PM10). It also estab-
lished new PM NAAQS for particles with
aerodynamic diameters < 2.5 µm (PM2.5), as
excess mortality was found to be more strongly
associated with PM2.5 than with PM10. 
The U.S. EPA (and CASAC) acknowl-
edged that the database supporting the
judgments that PM2.5 and PM10 exposures
were likely causal factors for adverse health
effects was not fully supported by, or consis-
tent with, available knowledge of the underly-
ing biological mechanisms. Among the likely
factors for discrepancies between observations
in human populations and corresponding
observations in controlled animals and
human studies are the following:
• Epidemiologic observations of adverse
effects had largely been confined to
subpopulations who may have been espe-
cially susceptible because of underlying pre-
existing disease or who were very young or
very old. In contrast, because of practical
and ethical considerations, most human
clinical studies had examined effects in
small groups of healthy individuals of inter-
mediate ages. Similarly, most previous ani-
mal studies focused on healthy and younger
animals and used exposures to concentra-
tions that were much higher than those
encountered in ambient air. 
• Toxicological studies have been limited, as
the most active components of PM remain
a matter of speculation. Subsequent studies
would need to use more realistic ambient
mixtures, e.g., concentrated ambient air
particles (CAPs) or laboratory-generated
surrogates that focus on specific particle
characteristics such as particle size [e.g.,
ultrafines (diameters less than 0.1 µm)]
and/or chemistry [e.g., metals, polycyclic
aromatic hydrocarbons (PAHs), quinones].
In addition, it is possible that responses may
require a mixture of PM components
and/or the simultaneous or sequential expo-
sure to gaseous pollutants in the ambient air
mixture [e.g., SO2, NO2, O3, CO, and
volatile organic compounds (VOCs)].
• No laboratory-based toxicological studies
have been conducted involving chronic or
even subchronic exposures to ambient air
PM mixtures at concentrations at the upper
end of the range of current U.S. ambient air
concentrations.
As a result of the remaining scientific
uncertainties, in 1998 Congress directed the
U.S. EPA to substantially increase its level of
funding on PM health effects research. It also
mandated that a National Research Council
(NRC) committee (i.e., the Committee on
Research Priorities for Airborne Particulate
Matter) be established to provide scientific
oversight for the PM research. In the ﬁrst of
its three reports, the NRC Committee on
Research Priorities for Airborne Particulate
Matter recommended a multiyear research
program that included the establishment of
academically based research centers to create a
comprehensive and integrated particle health
effects research program. The PM centers
were intended to foster interdisciplinary col-
laborations within and among institutions
with extensive experience in air pollution
health effects research. Research that arose
through these collaborations were in turn
intended to help the U.S. EPA address scien-
tiﬁc issues about PM health effects in a timely
and effective manner.
The U.S. EPA through its Science
to Achieve Results (STAR) program for
investigator-initiated research issued a request
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Research | Reviewfor proposals (RFPs) for centers for PM
health effects research in 1998. It received
and peer-reviewed 21 applications, and
awarded five center grants in the summer of
1999. The successful applicants were (in
alphabetical order)
•A  California consortium, headquartered at
University of California Los Angeles
(UCLA; Los Angeles, California)
• Harvard University (Boston, Massachusetts)
• New York University (NYU; New York,
New York) 
• The University of Rochester (Rochester,
New York)
• The University of Washington (Seattle,
Washington).
The U.S. EPA in its RFP specified that
a) each center have an external scientiﬁc advi-
sory committee to ensure that its research
program addresses important knowledge gaps
and is scientiﬁcally sound (each of these com-
mittees include members from academic insti-
tutions, industrial companies, public interest
groups, and some U.S. EPA scientists);
b) center directors have an annual meeting
with U.S. EPA scientists and administrators
for the exchange of information, progress,
and future plans, and for coordination of col-
laborative research; and c) each center have an
outreach program to communicate to the
public current knowledge of air pollution
health effects and research progress being
made to address knowledge gaps.
The centers have addressed these require-
ments and initiated collaborative activities.
These include sponsorship of scientiﬁc work-
shops to further research in key areas such as
characterizing cardiac health effects associated
with PM exposures, assessing costs and health
benefits of air pollution controls, examining
the health impacts of gasoline emissions in
California, and apportioning PM sources and
their associated health effects.
Through their individual and collective
activities during the initial years of the PM
health effects research centers, real progress
has been made toward the understanding of
ambient air pollution health effects and
addressing areas of remaining scientiﬁc uncer-
tainty. The PM centers plan to continue to
conduct both epidemiological and toxicologi-
cal studies to enhance our understanding of
the health effects associated with ambient PM
exposures. Of particular interest will be inves-
tigations of chronic PM health effects. This
research objective is consistent with the U.S.
EPA multiyear plan for PM research as
deﬁned in its November 2001 presentation to
the NRC Oversight Committee. 
This report provides a synopsis of the cen-
ters’ research accomplishments to date. Many
of the research studies presented received
major support from PM center funds. For
others, primary support was from other
sources, such as the National Institute of
Environmental Health Sciences (NIEHS) and
the Health Effects Institute (HEI), with the
availability of PM center core services and
interactions with other PM center investiga-
tors providing important supplemental sup-
port. This report consists of six sections.
Sections 1–5 address issues relating to 1) bio-
logical mechanisms, 2) acute effects,
3) chronic effects, 4) dosimetry, and 5) expo-
sure assessment. Section 6 summarizes the
features of the PM centers program that have
facilitated the harnessing of the skills and
resources of the PM center investigators for
collaborative research addressing the U.S.
EPA PM NAAQS development. Each of the
ﬁve key area sections begins with background
summarizing the challenge faced by the PM
centers as they began their centers program in
terms of what was known and what goals
were established to address key knowledge
gaps. These background summaries are fol-
lowed by an outline of progress that has been
and is being made by PM center investigators
in resolving knowledge gaps. The report also
outlines short-term goals (during the 2.5
remaining years of center support) and long-
term goals (beyond the initial 5 years of
center support) for the PM centers. 
The PM centers’ approach has been
highly interactive both within each center
and across centers, combining research efforts
on exposure/source characterization, epi-
demiological and toxicological effects, and
biological mechanisms summarized in
Figure 1. Continuous interdisciplinary dia-
logue among the PM center scientists assures
that the total breadth of PM research is cov-
ered and that new research ideas have a
sound scientific basis. This is accomplished
partly through periodic meetings among cen-
ter members from the different scientiﬁc dis-
ciplines represented in the centers. The
exposure assessors provide data on specific
ambient air PM constituents to toxicologists;
toxicologists provide information on the
relative toxicity of PM constituents to expo-
sure assessors and epidemiologists; the in
vitro toxicologists share insights with epi-
demiologists, clinicians, and animal toxicolo-
gists to help elucidate PM-specific response
mechanisms. This kind of collegial interac-
tion and sharing of research within and
among the centers is a special feature of the
PM centers program. The ﬁve research topics
listed in the center section of Figure 1 are the
areas jointly addressed by the five centers to
obtain results useful for the regulatory needs
of the U.S. EPA. Examples of progress in
these areas are provided in this special report.
Biological Mechanisms for
Particulate Matter Health
Effects
Background
Justifications for the 1997 PM10 and PM2.5
NAAQS were based primarily on a large and
coherent epidemiological database of signifi-
cant associations between ambient air PM
concentrations and excess mortality and mor-
bidity. Although the 1996 PM criteria docu-
ment provided some support for biological
plausibility of causal links between PM and
health effects, evidence from controlled
human and animal exposure studies was still
largely unavailable. On the basis of this infor-
mation gap, a major rationale for the estab-
lishment of the PM centers was to explore
biological plausibility and mechanisms of
PM-associated health outcomes. Over the
past 2 years, substantial contributions have
been made toward developing hypotheses
based on experimental observations, in large
part because of the research environment fos-
tered by the structure of PM centers. The fol-
lowing section provides examples of how the
PM centers program has contributed to the
development and testing of plausible mecha-
nistic hypotheses for the health effects of PM. 
Particle
characterization
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studies
Animal and
in vitro studies
Risk
assessment
Regulation
Implementation
Plausibility and
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Acute effects
Chronic effects
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Figure 1. PM center integration of research disciplines.
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have been investigated that may link PM
exposure with adverse health effects. Figure 2
highlights the complexity and interdepen-
dency of some of these pathways (Utell and
Frampton 2000). The portal of entry for PM
air pollution is the lung, and PM interactions
with respiratory epithelium likely mediate a
wide range of effects, as indicated by the cen-
tral oval in Figure 2. These include respira-
tory as well as systemic and cardiovascular
effects. However, PM, or its reaction prod-
ucts, may stimulate airway sensory nerves,
leading to changes in lung function and in
autonomic tone, which influence cardiac
function. Ultraﬁne particles by virtue of their
extremely small size may enter pulmonary
capillary blood and be rapidly transported to
extrapulmonary tissues such as liver, bone
marrow, and heart, with either direct or
indirect effects on organ function.
Progress in Biological Mechanism
Research
This section is a discussion of mechanistic
areas in which particular progress has been
made by the PM centers in inﬂammation and
immunity, mechanisms for cardiovascular
effects, and the role of reactive oxygen species
(ROS). This is not intended to be a compre-
hensive review but rather a summary of center
research programs. Many important studies,
particularly in vitro studies of PM mecha-
nisms, are not addressed.
Inflammation and immunity. Airway
injury and inﬂammation is a well-known con-
sequence of toxic inhalation exposures.
Previous studies involving animal models
have shown that instillation or inhalation of
particles such as diesel exhaust particles
(DEPs) can cause inﬂammation and epithelial
injury at high doses and concentrations.
However, there was little evidence prior to the
PM centers program that exposure to ambient
concentrations of PM caused significant air-
way inflammation. The presence or absence
of an inﬂammatory response is an important
issue because inflammation may induce sys-
temic effects, including an acute-phase
response with increased blood viscosity and
coagulability and possibly an increased risk
for myocardial infarction in patients with
severe coronary artery disease. In chronic res-
piratory diseases such as asthma and chronic
obstructive pulmonary disease (COPD),
inflammation is a key pathophysiologic fea-
ture. Chronic, repeated inflammatory chal-
lenge of the airways may result in airway
remodeling that leads to irreversible lung dis-
ease. Thus, inﬂammation may be involved in
both acute and chronic effects.
Following is a list of several key findings
from PM center research about the role of
inﬂammation and immunity in mediating the
health effects of PM. 
Particulate matter exposure and systemic
markers of inflammation in humans. The
PM centers in southern California and
Rochester, New York, have collaborated in
human clinical studies using identical
crossover exposure protocols, subject recruit-
ment criteria, and outcome measures. The
California studies used CAPs at approxi-
mately 200 µg/m3, and Rochester used
laboratory-generated carbonaceous ultrafine
particles at two concentrations—10 and
25 µg/m3. Preliminary ﬁndings from both of
these studies provide evidence for effects on
systemic markers of inﬂammation and leuko-
cyte recruitment (Boscia et al. 2000; Daigle
et al. 2002; Frampton et al. 2001). 
In both centers, subjects were exposed for
2 hr with intermittent exercise. Before and at
intervals after exposure, symptom ratings,
lung function testing, and phlebotomy were
performed. Sputum induction was performed
approximately 24 hr after exposure. In both
centers, blood was analyzed for markers of
systemic inﬂammation, acute-phase response,
and blood coagulability. One such marker is
soluble intercellular adhesion molecule-1
(sICAM-1), a transmembrane protein
expressed on leukocytes and endothelial cells.
sICAM-1 plays an important role in mono-
cyte recruitment to atherosclerotic lesions and
inﬂamed airways, where it is shed into plasma
during leukocyte adhesion. 
In the southern California CAPs studies,
sICAM-1 increased significantly (p < 0.05)
after exposure to CAPs (relative to ﬁltered-air
controls) for the pooled healthy and asth-
matic population. The effect was greater at
21 hr after exposure than at 4 hr. In the
Rochester ultraﬁne particle studies, no signiﬁ-
cant change was found in sICAM-1 in the
plasma of healthy subjects, but blood mono-
cyte expression of ICAM-1 decreased imme-
diately following particle exposure in a
concentration–response fashion compared
with air exposure. These studies suggest that
exposures to either CAPs or ultraﬁne particles
may initiate endothelial and leukocyte activa-
tion, with shedding of surface ICAM-1, a key
initial step in leukocyte recruitment. These
ﬁndings may have implications for cardiovas-
cular and respiratory disease. In a major car-
diac epidemiological study, plasma sICAM-1
levels were predictive of future coronary
events (Ridker et al. 1998).
Particulate matter exposure and inﬂam-
mation in animals. Studies in normal dogs
exposed to Boston CAPs by inhalation
showed increases in pulmonary inﬂammation
by bronchoalveolar lavage and in circulating
blood neutrophils associated with increases in
specific ambient particle components. In
these experiments, mean exposure doses were
203 and 361 µg/m3 in the lavage and blood
studies, respectively (Clarke et al. 2000).
These PM center studies show that ambient
particle components have significant pul-
monary and systemic inﬂammatory potential.
Similar ﬁndings have been reported in rats in
PM center studies (Saldiva et al. 2002).
Effects of aging. Determining the mecha-
nisms involved in increased susceptibility to
PM comprises another goal of PM center
research being explored at many levels. The
role of aging is being examined, using animal
and human exposure studies as well as in vitro
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Figure 2. Hypotheses for health effects of PM.
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cytokine production by alveolar macrophages
from aged rats and mice (> 20 months of age)
after in vitro exposure to lipopolysaccharide
(LPS) and PM. Macrophages from aged ani-
mals were incubated with endotoxin, with
laboratory-generated mixed carbon/iron ultra-
ﬁne particles, or with both. Baseline produc-
tion of cytokines was elevated 30–50% in
aged cells compared with cells from young
animals (8–10 weeks of age). The response to
LPS was enhanced at every dose in aged cells.
The response to ultraﬁne particles containing
iron was enhanced 2- to 3-fold in aged cells
compared with young cells. Most signifi-
cantly, in the aged animals, coadministration
of ultraﬁne particles and LPS led to synergis-
tic effects at the lowest ultraﬁne particle dose,
whereas in young cells this was observed only
at the highest PM dose (Finkelstein et al.
2002). These ﬁndings suggest a cellular basis
for age-related increased susceptibility that
may relate to increased susceptibility to oxida-
tive stress. Alternatively, the results may be
showing a lower threshold because of
impaired protective mechanisms (e.g., anti-
oxidant defenses). Investigations of these age-
related differences are currently focusing on
signal transduction mechanisms.
Effects on infection/pneumonia. Epidemi-
ological studies have demonstrated that infec-
tion, specifically pneumonia, contributes
substantially to the increased morbidity and
mortality among elderly individuals after expo-
sure to PM (Schwartz 1994), suggesting that
inhaled PM can act as an immunosuppressive
factor that undermines normal host pulmonary
immune responses. A combination of particle
concentrator technology and animal infectivity
models is being used to investigate this hypoth-
esis. A single 5-hr inhalation exposure of bacte-
rially infected rats to New York City CAPs, at
concentrations ranging from 65 to 150 µg/m3,
altered both pulmonary and systemic immu-
nity and exacerbated the infection process in a
time-dependent manner (Zelikoff et al. 1999).
Streptococcus pneumoniae–infected rats exposed
to PM demonstrated increased burdens of pul-
monary bacteria, numbers of circulating white
blood cells, extent of pneumococcal-associated
lung lesions, and incidence of bacteremia,
compared with air-exposed, infected control
rats. Conversely, this same PM exposure
resulted in decreased levels of lavageable poly-
morphonuclear neutrophils (PMNs),
bronchus-associated lymphoid tissue, and
proinﬂammatory cytokines [i.e., tumor necro-
sis factor-α, interleukin (IL)-1, and IL-6] in
infected rats. Subsequent studies implicated the
iron content in mediating these effects; many
of the ﬁndings were reproduced with nose-only
exposure to soluble iron but not with soluble
forms of other metals (manganese, copper, or
nickel). These findings suggest that PM
exposure, and specifically the soluble iron
component, may affect the host immune
response during pulmonary infection and may
help explain epidemiological observations. In
addition to the effects of iron, PM center
investigators have shown that DEPs and CAPs
induce apoptosis in macrophages by an oxida-
tive stress mechanism that is dependent on the
organic chemicals in the PM. Macrophage
apoptosis will lead to decreased phagocytic
defenses in the lung. 
Cardiovascular effects. Determining the
mechanisms linking ambient PM to cardio-
vascular effects is one of the key challenges of
the PM centers. There is growing clinical and
epidemiological evidence that ambient air
pollution can precipitate acute cardiac events
such as angina pectoris, cardiac arrhythmias,
and myocardial infarction, with the majority
of excess PM-related deaths attributable to
cardiovascular disease (CVD). The PM cen-
ters’ approach to this issue is multifaceted and
multidisciplinary. There are ongoing panel
studies of susceptible subjects involving
cardiovascular monitoring at three PM cen-
ters, animal exposure studies at four PM cen-
ters, and human clinical studies at three PM
centers. Three PM centers share a cardiac
monitoring and analysis protocol for human
clinical studies. 
A major step forward in this area was
made with the convening of a workshop,
“Cardiovascular Effects of Air Pollution:
Potential Mechanisms and Methods of
Testing,” which met in Rochester, New York,
in March 2001. The proceedings have now
been published (Utell et al. 2002), and
important research needs in this area have
been identified. The workshop featured pre-
sentations by PM center and other investiga-
tors, along with clinical and research
cardiologists. Each of the ﬁve U.S. EPA PM
centers participated in the workshop along
with representatives from the U.S. EPA. New
hypotheses and research directions were
developed, and practical issues of cardiac
monitoring methodology currently in use at
each PM center were reviewed and optimized.
This workshop grew directly from one of the
annual PM center directors meetings, where
the need for intercenter collaboration on this
issue was identiﬁed. The interchange of ideas
served as an important turning point in our
thinking about the mechanisms involved in
cardiac effects, and new collaborative efforts
were initiated. 
Key observations in both human and
animal studies of cardiovascular effects have
been made since the PM center program was
initiated. A few examples follow.
Human studies. Investigation of cardio-
vascular effects of PM has required multidis-
ciplinary collaboration. For human exposure
studies, analysis of cardiac monitoring
includes a detailed analysis of heart rate vari-
ability (HRV) and repolarization intervals
before, during, and for a period of 48 hr after
exposure. In one study (Frampton et al.
2002), healthy subjects were exposed by
mouthpiece for 2 hr with intermittent exer-
cise on three separate occasions to air or ultra-
fine carbon particles at 10 and 25 µg/m3.
Frequency-domain analysis of the continu-
ously recorded electrocardiogram (EKG) indi-
cated that response of the parasympathetic
nervous system was blunted during recovery
from exercise immediately after exposure to
ultrafine particles, compared with air. This
diminished vagal response was not observed
3.5 hr later. Monitoring also indicated that
exposure to ultraﬁne particles altered cardiac
repolarization, as indicated by the corrected
QT interval (QTc) on the cardiogram. The
increase in QTc following exercise during air
exposure was blunted with PM exposure, and
this persisted to at least 21 hr after exposure.
This change in repolarization was not
explained by changes in heart rate (Frampton
2001; Zareba et al. 2001). It is plausible that
ultrafine particle exposure imposes an effect
on repolarization, either through an indirect
effect via the autonomic nervous system or by
directly affecting ion channel function in ven-
tricular myocardium through a yet unknown
mechanism. This observation is important
because changes in the QT interval have been
implicated in susceptibility to cardiac arrhyth-
mias in patients with heart disease.
These human clinical studies are comple-
mented by a major panel study involving
patients with preexisting coronary artery dis-
ease in Erfurt, Germany. Analysis of the EKG
recordings and blood parameters are under
way, including detailed analyses of HRV and
repolarization, and acute-phase proteins using
methodology identical to the human clinical
studies. These clinical/epidemiological/toxico-
logical collaborations are examples of how the
PM centers program has fostered research
among diverse disciplines and locales.
Animal studies. Rats and mice are being
instrumented for continuous cardiac and
blood pressure monitoring. Algorithms have
been developed for analysis of heart rate and
blood pressure variability using continuous
24-hr recordings in up to eight rodents simul-
taneously (Couderc et al. 2002). A crossover
study with aging, spontaneously hypertensive
rats exposed to carbonaceous ultrafine parti-
cles is ongoing.
PM center investigators are evaluating
both inﬂammation and cardiovascular effects
in animal models. The hypothesis being tested
is that inhaled PM causes release of inﬂamma-
tory mediators from cells in the lung that then
become bloodborne and target the cardiovas-
cular system. The research plan uses transgenic
mouse strains with specific cardiovascular
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models. Initial studies have been using a
mouse model of atherosclerosis, the apoli-
poprotein E–deﬁcient mouse generated via a
targeted disruption of the mouse apo-E gene.
The deficiency of apo-E leads to a sponta-
neous hypercholesterolemia. The nonhyper-
tensive animals form atherosclerotic lesions
throughout the vasculature, which resemble,
in part, human atherosclerotic lesions at 3–5
months of age. Animals are instrumented and
monitored for blood pressure and heart rate
using radiotelemetry. Individual mice were
dosed with 125 µg Washington, DC, urban
dust in 50 µL saline by oropharyngeal aspira-
tion into the lungs. Heart rate was reduced
after exposure to PM in normal and in
apoE-/- mice. ApoE-/- mice showed a trend
to increased blood pressure and increased
variability of blood pressure after PM expo-
sure that did not differ signiﬁcantly from that
of the normal mice (Luchtel et al. 2002).
Additional experiments are being performed
as the control and apoE-/- mice age, and
studies involving more realistic exposures are
being planned. 
In another PM center study, male Fischer
344 rats 18 months of age with implanted
EKG transmitters were used to determine the
effects of PM on the frequency of sponta-
neous arrhythmias. As old rats (18 months of
age) were found to have many spontaneous
arrhythmias, a standardized definition for
each type of arrhythmia was developed, and a
procedure for quantifying the frequency of
spontaneous arrhythmias was established.
Rats were exposed to New York City CAPs or
filtered air for 4 hr. The rats were exposed
twice with a crossover design so each rat
could serve as its own control. The CAP con-
centration was 160 µg/m3 and 200 µg/m3 for
the first and second exposures, respectively.
EKG tracings demonstrated a significant
increase in the frequency of supraventricular
arrhythmias after exposure to CAPs compared
with ﬁltered air–exposed control animals. The
same rats were also exposed twice to 1 ppm
SO2 and twice to air in a repeated crossover
design. No significant change in the fre-
quency of any category of spontaneous
arrhythmia after exposure to SO2 (or ﬁltered
air) was observed (Nadziejko et al. 2001). 
The effects of PM on myocardial ischemia
have also been the focus of PM center research.
Inhaled PM exacerbated ischemia in a clini-
cally relevant model of coronary artery occlu-
sion in conscious dogs. Exposures to CAPs
significantly increased peak electrocardio-
graphic ST-segment elevation during a 5-min
coronary artery occlusion compared with sham
exposures in two different protocols using con-
scious dogs (Godleski et al. 2000; Wellenius et
al. 2003). The relationship of ambient particle
components to the degree of ischemia in dogs
is the focus of ongoing PM center research
(Wellenius et al. 2003). Other PM center stud-
ies have used an improved model of myocar-
dial infarction in the rat and demonstrated
increased ventricular arrhythmias with aerosol
exposure to oil ﬂy ash particles but not to car-
bon black particles (Wellenius et al. 2002).
This model of myocardial infarction is being
used to study the effects of combinations of
CAPs and carbon monoxide. In other studies
of the vascular response to inhaled particles, a
variety of cell and molecular biologic methods
have been used.
Reactive oxygen species. A major finding
has been that PM generates ROS, which pro-
vide proinflammatory stimuli to bronchial
epithelial cells and macrophages. These cellular
targets respond with cytokine and chemokine
production, which can enhance the response to
allergens. PM may therefore act as an adjuvant
that strengthens the response of the immune
system to environmental allergens. Hallmarks
of allergic inflammation include increased
immunoglobin E (IgE) production, eosino-
philic bronchial inﬂammation, airway hyper-
responsiveness, and an increase of nitric oxide
(NO) in exhaled air. 
This hypothesis is being tested using
in vitro and animal studies (Whitekus et al.
2002). In one study using an allergic mouse
model, animals were exposed at high doses to
nebulized DEPs (2000 mg/m3) for 1 hr, fol-
lowed by nebulized antigen [ovalbumin
(OVA)] for 20 min daily for 10 days. A con-
trol group received saline instead of DEPs fol-
lowed by OVA. To determine the role of
ROS, the same exposure groups were pre-
treated every day with intraperitoneal
N-acetylcysteine (320 mg/kg). Control ani-
mals received saline intraperitoneally. Two
days after the last exposure, blood was
obtained and assayed for IgE and IgG1, and
the lungs were assayed for carbonyl proteins
and lipid peroxides. DEPs markedly
enhanced the antibody response (Figure 3)
and lipid peroxidation, and these effects were
abrogated by antioxidant treatment. Follow-
up studies using more realistic exposure levels
of DEPs and/or CAPs are being planned.
Furthermore, human nasal challenge studies
conﬁrmed the role of DEPs as an adjuvant in
already established allergic responses, as well
as in exposure to neoallergens. Taken
together, these findings may explain the
increased number and severity of asthma
attacks in an urban setting after a surge in PM
levels, and may implicate DEPs as a factor in
asthma exacerbations. 
ROS associated with exposure to PM
may play a role in cardiovascular effects.
9,10-Phenanthroquinone (9,10-PQ) is a
potent inhibitor of neuronal form of nitric
oxide synthase (NOS). 9,10-PQ also inhibits
the endothelial form of NOS, which plays a
critical role in vascular tone, thereby causing
the suppression of NO-dependent vasorelax-
ation of aorta and significant increase in
blood pressure in rats. Therefore, quinones
and other compounds producing ROS, for
example, nitro-PAHs, may contribute to dis-
eases related to vascular dysfunction caused by
exposure. In addition to the production of
ROS, quinones, PAHs, nitro-PAHs, and
related compounds may also undergo elec-
trophilic addition to macromolecules produc-
ing complementary toxicity.
The key role of the PM centers in facili-
tating this line of investigation on ROS has
been the collaboration between scientists with
diverse expertise. For example, the collective
expertise in the southern California PM cen-
ter facilitated the use of CAPs to replace
DEPs for mechanistic in vitro and in vivo
studies. Asthma animal models are now being
used to compare the prooxidative and proin-
flammatory effects of CAPs collected on
California freeways and various source-
receptor sites. In addition, human panel stud-
ies and CAPs exposure studies now typically
include the role of oxidative stress in airway
inflammation (e.g., assays for NO and CO
content in the expired air, and measures of
cytokines in induced sputum, blood, and
breath condensate). 
Another important development by the
PM centers is collaboration among chemists,
engineers, and biologists in exploring how
chemical constituents of CAPs contribute to
ROS generation and inﬂammation. An impor-
tant observation has been that organic compo-
nents present in the organic carbon fraction
generate ROS through their ability to undergo
redox cycling. The in vitro reactions correlate
well with the ability of organic PM compo-
nents to generate oxidative stress in epithelial
cells and macrophages. Preliminary evidence
indicates that PAHs and their oxidized deriva-
tives (quinones and ketones) play a key role in
ROS generation at the cellular level. The
in vitro toxicity studies predict a hierarchical or
stratiﬁed oxidative stress response in which the
biological effects range from a) protective (e.g.,
expression of antioxidant enzymes); b) pro-
inflammatory (e.g., production of cytokines
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Figure 3. Thiol antioxidant interferes in the adjuvant
effects of DEPs during OVA sensitization in a
murine allergic inﬂammation model.and chemokines); and c) cytotoxic (e.g., cellu-
lar apoptosis and necrosis), depending on the
level of oxidative stress. The ability to relate
the inherent redox-cycling and oxidative stress
capabilities of a PM sample to speciﬁc biolog-
ical effects allows a more rational interpreta-
tion of the in vivo toxicity data being
generated in the community, freeway, and
source/receptor studies. 
Short-Term Particulate Matter
Research Goals in Biological
Mechanisms
Objectives of the PM centers during the
remaining funding period will include a
greater utilization of intercenter collabora-
tions. In addition to the collaborative efforts
described in this section, new interactive cen-
ter initiatives will elucidate mechanisms of PM
effects. These include sharing of PM collected
from various sources at different PM centers
for use in animal and in vitro studies, sharing
of exposure technology, and developing
common laboratory protocols. 
An important objective will be to identify
additional mechanistic links. For example,
neural pathways may play a role in mediating
cardiovascular effects. If studies currently
under way confirm that PM affects auto-
nomic regulation of cardiovascular function,
we will need to further deﬁne the mechanisms
by which those effects are initiated, including
the cells and cell mediators responsible.
Research on these mechanisms will provide
vital clues about individual susceptibility and
potential approaches to the prevention of
adverse health effects.
Animal studies based on the hierarchical
or stratified oxidative stress model are being
planned and will consider the possible identi-
fication of susceptible human subjects with
weakened oxidative stress defenses. This could
involve polymorphisms of the heme oxyge-
nase 1 gene, which is a very sensitive anti-
oxidant defense mechanism that protects cells
against redox-cycling DEPs chemicals and
contributes to CO and NO production dur-
ing in vivo DEP exposure. The elucidation of
susceptible individuals who can be studied
with rational end points will enhance epi-
demiological studies and will also help to
monitor the impact of regulatory measures to
reduce adverse health effects.
A continuing research objective is to
further examine the role of PM composition,
size, surface area, gaseous co-pollutants, and
other factors in mediating effects. This
involves a variety of experimental approaches,
from detailed morphologic and chemical
analysis of ambient air PM to in vivo and
in vitro exposure studies using both CAPs and
laboratory-generated PM of carefully deﬁned
composition. A related longer-term goal is to
determine the role of complex mixtures in
eliciting health effects using factor analysis to
identify the sources of PM and associated
gaseous air pollutants. 
Determining the mechanisms underlying
individual susceptibility to PM effects is
another major objective under way in each of
the PM centers. Host susceptibility factors
being investigated include age, gender, under-
lying disease, infections, and genetic factors. 
A key goal of PM centers research is to
develop biologic markers of speciﬁc mechanis-
tic pathways that can be used to link ﬁndings
from animal, human, and epidemiological
studies. Many examples are currently being
investigated, including plasma sICAM-1 and
monocyte ICAM-1 as indicators of enhanced
leukocyte endothelial interaction, and meas-
urement of changes in HRV as a measure of
cardiovascular autonomic effects. 
Long-Term Particulate Matter
Research Goals in Biological
Mechanisms
One major long-term objective of the PM cen-
ters is to determine the mechanisms involved
in chronic health effects of ambient PM expo-
sure. Epidemiological studies have indicated
that exposure to PM2.5 leads to a shortening of
life span, and this ﬁnding was a major impetus
in the establishment of the annual average
PM2.5 NAAQS. Does PM2.5 exposure exacer-
bate underlying disease or contribute to the
genesis of disease (or both)? Some of the key
ﬁndings currently being investigated in the PM
centers, and summarized here, have implica-
tions for chronic (long-term) effects. 
For example, one hypothesis is that recur-
rent inﬂammatory or allergic challenges to the
airway leads to airway remodeling, a key fea-
ture in the development of irreversible airways
obstruction in asthma and COPD. Second,
there is growing evidence that atherosclerotic
CVD is an inﬂammatory process. PM centers
are testing the hypothesis that immune or
inflammatory effects of PM exposure may
promote or accelerate atherosclerosis. Third,
diabetes is associated with severe, accelerated
atherosclerotic vascular disease and increased
susceptibility to infection, and a recent study
identiﬁed diabetics as particularly susceptible
to the health effects of PM. Determining the
mechanisms involved in this susceptibility of
diabetics may help shed new light on PM
effects mechanisms in general.
Ambient air PM contains carcinogens,
and recent epidemiological evidence indicates
that mortality due to lung cancer is increased
in relation to PM2.5 exposure. Investigating
the PM components and mechanisms for
carcinogenesis will be an important long-term
goal of the PM centers.
Finally, major long-term goals of the PM
centers are to contribute new scientiﬁc data and
risk assessment tools and information that will
assist in reﬁning air quality standards for PM,
and to evaluate the public health benefits of
reductions in PM exposure. This will involve
more comparisons of PM potency across ani-
mal, clinical, and in vitro end points coupled
with ever-increasing specificity as to aerosol
characteristics, leading to better indicators of
biological mechanism and links of particular
sources of PM to speciﬁc health effects.
Acute Health Effects 
of Particulate Matter
Background
The acute health effects of PM exposures have
been extensively examined by a large number
of epidemiological studies conducted world-
wide. These studies have consistently shown
signiﬁcant associations between daily average
ambient PM concentrations and correspond-
ing cardiopulmonary mortality, morbidity,
and functional impairments. When the U.S.
EPA promulgated its 24-hr PM2.5 NAAQS in
1997, it relied primarily on this large body of
epidemiological data relating PM exposures to
daily deaths and hospital admissions.
However, critics of the revised PM NAAQS
raised a number of key issues in their chal-
lenges to the credibility of, or need for, a new
24-hr PM2.5 NAAQS, such as a) the associa-
tions represented deaths of frail individuals
whose deaths were brought forward by only a
few days or weeks (harvesting), and thus had
little public health significance; b) particles
originating from different sources have varying
toxicities; therefore, the relative health impacts
of particle sources should be assessed prior to
regulating their emissions; c) the associations
were potentially confounded by season,
weather, and other gaseous pollutants; d) the
associations were implausible because ambient
PM2.5 concentrations were not appropriate
surrogates of personal PM2.5 exposures; e) the
associations were implausible because there
was limited support from controlled human
and animal studies; f ) the identification of
populations susceptible to PM2.5 health effects
is necessary prior to promulgating a new
PM2.5 standard; and g) the exposure–response
curves, showing no thresholds, were unlikely
from a biological standpoint. 
Many of these issues have been addressed
in recent epidemiological and toxicological
investigations examining the acute health
effects associated with short-term PM expo-
sures. Collaborations between epidemiologi-
cal and toxicological communities have led to
the development of common study hypothe-
ses and common health end points such as
lung function, arterial oxygen saturation,
heart rate, HRV, blood pressure, tissue bio-
markers of effects, exhaled nitric oxide
(eNO), cardiac dysrhythmias, and respiratory
symptoms. As a result, our understanding of
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advanced. For example, results from recent
controlled laboratory studies have shown that
short-term exposures to CAPs, compared
with artificially generated particles, result in
acute health effects comparable to those
reported in the epidemiological literature.
These toxicological findings provided some
evidence about biological plausibility and
mechanisms that will be of paramount impor-
tance to our efforts to examine the validity of
the observed epidemiological study ﬁndings. 
Progress Made in Acute Effects
Research
Since the establishment of the PM centers,
substantial progress has been made in our
understanding of PM health effects.
Collectively, the PM centers have addressed a
large number of scientific issues regarding
acute PM health effects. These investigations
are broadly categorized as either observational
or controlled studies. It has recently been
reported that the S-Plus Software (MathSoft,
Inc., Cambridge, MA) fails to adequately meet
the convergence criteria nominally applicable
to multiply smoothed data in studies of acute
health effects of air pollution (Dominici et al.
2002). Center investigators who have used this
software have reanalyzed many of their recent
studies using the new default criteria of
Dominici et al. (2002), and although small
changes in effect size estimates have been
made, none of them necessitated changes in
the conclusions drawn from these studies.
Observational studies. Harvesting. If air
pollution–related deaths mainly affect already
frail or sick individuals whose deaths are
being brought forward by only a few days (the
harvesting hypothesis), then PM-related mor-
tality would have little or no importance on
total mortality rates. Studies examining the
harvesting hypothesis were conducted by the
PM centers. Using a series of moving averages
of mortality and exposure data (7-day, 15-
day, etc.), Schwartz (2000a) examined
whether the strength of the associations
changed over the various averaging periods.
On the basis of the harvesting hypothesis, one
would expect that estimated PM-mortality
associations would become weaker as the
averaging periods increased. However, the
results from this analysis showed that the
association between PM10 and mortality
remained signiﬁcant, and the estimated rela-
tive risks were, in fact, higher for the longer
averaging periods. Similar results were found
for hospital admissions data (Schwartz 2001).
An alternate analytical approach was used in a
10-city meta-analysis study, where averaging
periods were increased incrementally from 1
to 45 days. Results from this analysis showed
that the PM effect increased by a factor of
2.5, again suggesting signiﬁcant shortening of
life (Zanobetti et al. 2002). Similar analyses
are currently being conducted to examine
cause-speciﬁc mortality. 
Threshold/exposure response. Analytical
methods were developed to combine smoothed
exposure–response curves from multiple loca-
tions to examine whether a threshold in the
PM10 and daily death relationship exists.
Results from multiple cities in the United States
and Spain suggest that the PM10-mortality rela-
tionships are linear down to the lowest observed
exposure concentrations, supporting the no-
threshold hypothesis (Schwartz and Zanobetti
2000; Schwartz et al. 2001). Similar results
were found in subsequent studies of PM2.5 and
mortality in six U.S. cities and of PM10 and
hospital admissions. In the PM10-hospital
admissions study, the methodology was modi-
ﬁed to examine sources of heterogeneity in the
exposure–response relationship by calculating a
random slope for each city. In the near future,
we plan to apply the random slope model to
mortality data and to examine other responses
to PM exposures, such as EKG changes. 
Particle-specific associations. PM center
investigators have examined the relationship
between mortality and source-specific PM
concentrations. Laden et al. (2000) used
source-apportionment techniques to group
elemental PM concentrations from six U.S.
cities into a small number of categories, or
“factors.” These factors were attributed to dif-
ferent PM sources such as vehicular emissions,
oil combustion, and soil. For each factor, a
daily score was calculated. Subsequently,
excess daily mortality was regressed against the
daily scores using multiple regression analyses.
Significant associations were found between
mortality and the trafﬁc and coal combustion
factors, with the largest effect size for the traf-
fic factor. No significant associations were
observed for the oil and soil factors. Mar et al.
(2000) applied factor analysis to PM2.5, PM10,
PM10–2.5, sulfates, non–soil PM2.5, organic
carbon, elemental carbon, total carbon,
gaseous co-pollutants, and cardiac mortality
data in Phoenix, Arizona. Results from this
study showed that combustion-related pollu-
tants and sulfates were associated with cardio-
vascular mortality. Source-speciﬁc effects were
also examined by Janssen et al. (2002), who
used source emission and home characteristics
to explain observed variability in the city-spe-
ciﬁc PM10-hospital admissions coefﬁcients. As
shown in Figure 4, the PM10 coefficient for
CVD-related hospital admissions increased
with the fraction of PM10 emissions from
trafﬁc-related sources, suggesting higher rela-
tive risks from PM10 for cities with a greater
number of trafﬁc-related PM10 sources. 
Susceptibility. Several studies have shown
higher PM-associated health risks for suscep-
tible subpopulations such as the elderly or
those with existing cardiopulmonary diseases.
PM center investigators have attempted to
identify important susceptible subpopula-
tions. Results from these studies have shown
that socioeconomic factors and race do not
affect susceptibility to PM-associated mortal-
ity (Zanobetti and Schwartz 2000); however,
females were shown to be at greater risk. 
The elderly have long been thought to be
particularly susceptible to PM pollution.
Consequently, several panel studies have
focused on examining the impact of PM expo-
sures on the elderly. In Seattle, Washington,
the relationship between outdoor PM concen-
trations and cardiopulmonary health effects
was examined for three panels of elderly sub-
jects (healthy, with CVD, and with COPD).
Results from this study showed that during
paced breathing exercises, an increase in out-
door PM2.5 (lagged by 1 hr) was associated
with a decrease in the median of high fre-
quency heart rate variability (HF HRV) in
subjects with CVD (Sullivan et al. 2002).
Decreases in HF HRV were also observed for
4- and 24-hr lagged periods. No effects were
observed either for healthy subjects or those
with COPD. However, results from these
studies have not been entirely consistent, as a
recent study showed no signiﬁcant association
between PM2.5 exposure (0- to 2-day lag) and
coached FEV1 (forced expiratory volume in
1 sec) for subjects with COPD or CVD. In
contrast, local outdoor PM2.5 concentration
was associated with a decrement in FEV1 for
normal subjects without reported COPD or
CVD (Trenga et al. 2002).
Other PM center–sponsored studies exam-
ining whether individuals with preexisting dis-
ease are at increased risk from PM exposures
are currently under way. Data collection and
analyses for a study in Erfurt, in eastern
Germany, of patients with preexisting CVD
or COPD is currently being conducted to
examine whether ultraﬁne particles exacerbate
CVDs through different mechanisms than
PM2.5 (Wichmann and Peters 2000). Analyses
of 683 EKG recordings and blood parameter
analyses are ongoing. Fieldwork for the study
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Figure 4. Association of motor vehicle PM10 and
CVD hospital admissions. The size of the symbol
reﬂects the size of the population group studied.
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and was completed in spring 2002.
Children may also be particularly
susceptible to PM exposures. Koenig et al.
(2002) conducted a study of 16 children
(6–12 years of age) with mild to moderate
asthma living in Seattle. Daily samples of
eNO, a marker of pulmonary inﬂammation,
were collected for each of these children for up
to 10 consecutive days. Results from this study
showed that an increase in PM2.5 was associ-
ated with an increase in eNO, suggesting that
PM2.5, at ambient concentrations, can act as
an inﬂammatory agent.
In an additional study conducted in
Seattle, 133 children (5–13 years of age) with
asthma were observed for an average of 58
days (range 28–112 days) while they were
screened for enrollment in the Childhood
Asthma Management Program study (Yu
et al. 2000). In single-pollutant models, the
population average estimates indicated an
increase of 18% in the odds of an asthma
symptom corresponding to a 10 µg/m3 incre-
ment in same-day PM10 and an increase of
11% for PM10 lagged 1 day. 
More recently, diabetics have been identi-
fied as an important susceptible population.
In several single-city studies, the risk of PM-
associated hospital admissions for heart dis-
ease for diabetics was double that for the
general population (Zanobetti and Schwartz
2001, 2002). In addition, diabetics had an
increased risk of PM-associated mortality
(Bateson and Schwartz 2001). Individuals
with other preexisting diseases were also at
higher risk. Respiratory illness, for example,
modified the risk of cardiovascular hospital
admissions, whereas heart failure was found
to modify the risk of COPD hospital admis-
sions (Zanobetti et al. 2000). 
Confounding. A new hierarchical model
was used to examine the potential confound-
ing effect of gaseous co-pollutants (Schwartz
2000b). The results of this study suggest that
the association between PM10 and daily
deaths was not confounded by gaseous air
pollutants. A subsequent examination of the
season-speciﬁc relationship between PM and
mortality data for Philadelphia, Pennsylvania,
confirmed that mortality was predominantly
associated with PM2.5 and not SO2 (Schwartz
2000b). Additional information about con-
founding was provided by exposure studies,
which showed that ambient gaseous air pollu-
tant concentrations are not well correlated
with their respective personal exposures but
are significantly correlated to personal PM
exposures, suggesting that the ambient gaseous
concentrations are acting as surrogates for per-
sonal exposures to PM (Sarnat et al. 2001; also
see “Exposure Assessment”). 
Controlled animal and human studies. A
large number of controlled exposure studies in
humans and animals have been conducted by
the PM centers in an effort to investigate the
acute biological responses induced by PM
exposures. Some of these studies have used lab-
oratory-generated PM, whereas others have
relied on particle concentrators developed by
aerosol scientists at the PM centers to speciﬁ-
cally serve the needs of their health effects col-
leagues. This makes it possible to simulate
upper-bound PM2.5 concentrations on a regu-
lar and prolonged basis to examine the cardiac
and pulmonary function, response biomarkers,
and other health end points before, during,
and after exposures. 
Results from these studies have repeatedly
shown associations between PM2.5 exposures
and a variety of acute responses, providing
direct evidence that PM2.5 is biologically active
at current peak exposure levels. As described in
“Biological Mechanisms for Particulate Matter
Health Effects,” health outcomes that may war-
rant further examination in epidemiological
studies include heart rate, HRV, QTc interval
changes, arrhythmias and ischemia, blood
ICAM-1 and IL-6, and oxidant stress markers.
Some brief descriptions follow controlled acute
health effects of animals and humans con-
ducted by the PM centers.
Animal studies. Ovalbumin-sensitized
mice were exposed in a specially equipped van
located 50 meters downwind of a Los Angeles
freeway. Groups of mice were exposed to CAPs
at two concentrations (400 µg/m3 and 800
µg/m3) for 5 or 10 days. Control mice were
exposed to puriﬁed air under the same condi-
tions. All mice received an inhalation challenge
of OVA 2 weeks after their last CAPs or air
exposure. As illustrated in Figure 5, eosinophils
and OVA-IgE were increased, relative to con-
trols, after the 5- and 10-day exposures at 400
µg/m3 (p = 0.05 for 10-day exposure) but not
after exposure to 800 µg/m3 for 5 days. The
mice exposed to 800 µg/m3 for 5 days were not
different from controls and were suppressed
with respect to eosinophils and IgE compared
with 400 µg/m3 for 10 days. These preliminary
results are consistent with a multiphasic
immunological response to CAPs. It is possible
that exposures to high CAPs concentrations
can have cytotoxic effects that suppress allergic
responses, whereas exposures at lower CAPs
concentrations can stimulate allergic responses. 
The age-resolved response of sensitized
rodents was examined using 6-hr exposures to
laboratory-generated ultraﬁne carbon particles
(100–150 µg/m3) with and without O3 co-
exposures (Elder et al. 2000, 2002). Results
showed that age, ultraﬁne particle concentra-
tion, ozone concentration, and sensitizing
agents were signiﬁcantly associated with cellu-
lar and biochemical lung lavage analysis and
oxidative stress-related parameters of lavage
and blood cells, and acute-phase proteins.
Compared with young animals, old rodents
were at increased risk for greater oxidative
stress from combined ultrafine carbon and
ozone exposure.
Human studies. Eleven human volunteer
subjects who were either healthy or had
asthma were exposed to inhaled carbon ultra-
fine particles by mouthpiece for 2 hr (~ 2 ×
106 particles/cm3; count median diameter =
22 nm) (Frampton et al. 2002). Healthy sub-
jects showed no signiﬁcant response to expo-
sure, as determined by symptoms, spirometry,
pulse oximetry, exhaled NO, or sputum cell
differential (counts compared with air con-
trol). PMN expression of ICAM-1 and leuko-
cyte function–associated antigen-1 decreased
3.5 hr after exposures but to a greater degree
after ultrafine particle exposure than filtered
air exposure. 
For healthy subjects (n = 12), an ultraﬁne
count concentration–response decrease in solu-
ble CD40L was seen compared with air expo-
sure (p = 0.006) (Daigle et al. 2002). An
interim analysis was performed on eight sub-
jects with asthma. CD40L expression on
monocytes, a marker of adverse inﬂammatory
responses, increased after PM exposure relative
to air exposure (p = 0.047). There were no
changes in lung function or airway production
of NO. These observations are the first evi-
dence of CD40–CD40L changes following
exposures to ultraﬁne particles and are consis-
tent with previous ﬁndings of altered leukocyte-
endothelial interactions after such exposures.
Human volunteers were exposed to PM2.5
CAPs in Los Angeles. Exposure to PM2.5
induced decreased HRV in healthy young
adults; increased blood ICAM-1 (indicating
increased inflammation and coagulability),
which was similar in healthy and asthmatic
adults; marginally significant increases in
serum IL-6, an acute-phase reactant, in asth-
matics; transient decreases in arterial oxygen
saturation in elderly subjects; decreased HRV
in elderly subjects; a greater number of supra-
ventricular and ventricular ectopic heartbeats
in elderly subjects; and increased IL-6 in
induced sputum, suggesting increased airway
inﬂammation. 
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Figure 5. Responses of mice exposed approximately
50 meters downwind of freeway to CAPs and OVA.
Group sizes = 9. Error bars represent mean ± SE.
*Signiﬁcantly different from control (p < 0.05).
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results are beginning to elucidate the roles of
key exposure variables on biological responses.
These ﬁndings not only support the epidemi-
ological observations but also provide new
information about the biological outcomes
that can be measured in ﬁeld studies.
Short-Term Goals in Acute Effects
During the next several years, the PM centers
will continue to develop and apply new analyt-
ical techniques to address important scientiﬁc
issues relating to harvesting, confounding,
exposure–response relationships, and suscepti-
bility. The novel statistical approaches devel-
oped for evaluating harvesting will be applied
to additional U.S. populations for a variety of
health outcomes. In addition, these new
methodologies will be used to examine the
relationship between acute and subacute
effects. These investigations will, in turn, pro-
vide valuable insights for our efforts to quantify
chronic PM health effects. 
Furthermore, we will continue to investi-
gate the potential for confounding by gaseous
co-pollutants and the exposure–response rela-
tionships in a variety of urban environments
with different mixtures of gaseous and partic-
ulate pollutants.
Over the past few years, the PM centers
have been successful in identifying suscepti-
ble populations. These studies suggest that
individuals with cardiac and pulmonary dis-
eases are more vulnerable to PM exposures,
and diabetics have been identified as an
important susceptible population. Obser-
vational studies will continue to be critical in
our efforts to understand susceptibility.
Indeed, on the basis of the results of previous
observational studies, PM centers have been
able to develop animal models replicating
human susceptibility.
Investigation of the relationship between
particle composition or source characteriza-
tion and adverse health outcomes will con-
tinue to be a main focus of the PM center
research agendas, and the data now being
generated by the U.S. EPA speciation and
Supersite monitoring programs will be used
in this endeavor. We will also investigate the
impact of DEP exposures on the exacerbation
of asthma. Similarly, we will examine the rela-
tionship between freshly generated ultrafine
particles from mobile sources and children’s
acute health effects, using the residence loca-
tion relative to major interstate roadways as a
marker of exposure. 
The PM centers observational studies will
be supplemented by a series of animal toxicol-
ogy studies that will also be completed during
the next few years. The main objective of these
controlled studies will be to investigate the
pulmonary and cardiovascular effects induced
by exposures to concentrated ﬁne and ultraﬁne
particles and gaseous co-pollutant mixtures.
Of particular interest will be identiﬁcation and
evaluation of susceptible models. For example,
we will conduct studies exposing mice and rats
to concentrated ﬁne and ultraﬁne particles at
varying distances from high-volume interstate
highways in southern California to determine
the effects associated with freshly generated
vehicular emissions. In addition, collaborative
studies will be performed to examine the vari-
ability in the PM-induced biological responses
in animal hosts (e.g., pulmonary immuno-
modulation) as a function of PM composi-
tion. Toward this end, PM centers will collect
and exchange PM2.5 samples containing parti-
cles of substantially different physicochemical
characteristics. 
Collectively, the acute observational and
controlled investigations will enable us to
enhance our understanding about the nature
of transient cardiac function changes associ-
ated with short-term peaks in PM exposures;
the role of underlying ischemia on associations
between short-term peaks of PM exposure and
incident myocardial infarction; and the role of
underlying respiratory disease on associations
between PM exposures and HRV.
Long-Term Goals in Acute Effects
We anticipate that many of the scientific
issues addressed in the above list of short-term
goals will not be adequately resolved during
the next 2–3 years. Therefore, it is likely that
research on many of these issues will comprise
much of our long-term agenda on acute PM
health effects. Among these issues will be
research-investigating factors, both environ-
mental and genetic, that explain human sus-
ceptibility. In addition, we expect that future
collaborative investigations between epidemi-
ologists and toxicologists will lead to the
development of better biomarkers of PM
effects. Finally, PM center efforts aimed at
quantifying the acute health effects of PM
exposures will ultimately assist in the creation
of new chronic PM health effects models.
Chronic Health Effects 
of Particulate Matter
Background
As discussed in the previous section, a plethora
of PM acute health effects studies have been
conducted to date. In contrast, much less infor-
mation is available on chronic effects associated
with PM exposures. This is because of the com-
plexity and cost of chronic effect studies.
The most frequently cited PM chronic
health effect studies are the Harvard Six Cities
Study (Dockery et al. 1993) and American
Cancer Society (ACS) Cohort Study (Pope
et al. 1995). They found increased mortality
rates (decreased life expectancy) in cities with
higher average ambient PM2.5 and sulfate
concentrations. Differences in city-specific
mortality rates were not explained by data on
personal risk factors. Because these studies
provided most of the justification for the
annual PM2.5 NAAQS in 1997, they gener-
ated a number of concerns that were
expressed in public comments that questioned
a) the validity of underlying study findings
due to the lack of public access to raw data;
b) the adequacy consideration of city-speciﬁc
characteristics and other alternative explana-
tions of the observed differences in mortality
rates; c) the adequacy of controls for the indi-
vidual characteristics such as age, smoking,
occupation, obesity, and socioeconomic fac-
tors; and d) the appropriateness of ambient
PM measurements as surrogates of commu-
nity personal exposures. 
In addition to mortality in adults, increased
respiratory effects in children associated with
long-term PM exposures were reported. The
Harvard Six and Twenty-four Cities cross-sec-
tional studies observed higher rates of respira-
tory symptoms (Dockery et al. 1996) and lower
lung function (Raizenne et al. 1996) for chil-
dren in cities with higher average PM2.5 and
acidic sulfate concentrations. Concerns
expressed in public comments at CASAC
reviews of the PM Criteria Document and Staff
Paper were similar to those expressed for the
mortality studies, except for the influence of
smoking and occupation. 
There were effectively no animal studies
of mortality or other morbidity end points of
chronic PM exposures consistent with the
epidemiological findings. Long-term studies
had shown increased lung cancer in rats
exposed to very high concentrations of DEPs
or carbon particles (possibly related to the
particle clearance overload they produced). 
Because of the high visibility of the Six
Cities and ACS cohort studies and their inﬂu-
ence in the standard setting process, the HEI
undertook sponsorship of a comprehensive
independent validation and reanalysis of these
studies. The HEI project (Krewski et al.
2000) validated the quality of the original
annual mortality study data, replicated the
original ﬁndings, and demonstrated the valid-
ity and robustness of Six Cities and ACS
Mortality studies findings. For both of the
cohorts studied, PM-associated mortality risk
was highest for individuals with less than high
school educations.
Data from other chronic exposure mortality
studies have been limited. Survival analyses of
nonsmokers in California (the Adventist Health
and Smog Study) reported increased mortality
associated with PM2.5 concentrations (Abbey et
al. 1999). Preliminary analyses of male veterans
being treated for hypertension reported no sta-
tistically signiﬁcant increased mortality associ-
ated with ﬁne particle concentrations (Lipfert
et al. 2000).
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Annual mortality cohort studies. Two of the
PM centers have been engaged in continued
follow-up of the original Six Cities and ACS
cohorts, respectively, for an additional 9
years. New data on occupation and other
individual characteristics as well as new ana-
lytic methods developed in the HEI reanaly-
ses were applied in both studies. These recent
findings are illustrated in Figure 6. The
updated ACS study involves the analysis of
more extensive PM2.5, sulfate, and gaseous
co-pollutant data. For the Six Cities cohort,
PM2.5 and sulfate concentrations continued
to be associated with decreased survival and
with increased mortality from cardiovascular
and pulmonary causes (Laden et al. 2001). In
addition, increased lung cancer deaths were
significantly associated with PM2.5 and sul-
fates in the extended follow-up. For the ACS
cohort, PM2.5 and sulfate also continued to
be associated with increased cardiovascular
and pulmonary mortality, and there was also
an excess of lung cancer (Pope et al. 2002).
The excess risks in the ACS cohort were seen
only among individuals with less than high
school educations in these extended analyses.
Effects of subchronic exposures. Recent PM
center analyses have attempted to bridge the
time spans for health effects observed in stud-
ies of acute daily exposures versus long-term
chronic exposures. Analyses of the association
between daily mortality and hospital admis-
sions with PM concentrations during the pre-
ceding weeks to months have highlighted the
importance of subchronic exposures. In
Boston, for example, an increase in the 2-day
average PM2.5 of 10 mg/m3 was associated
with an increase in mortality by 2.1%, while
for the same increase in monthly average,
mortality increased by 3.8% (Schwartz
2000a). In the ACS cohort study, this same
increase in annual average PM2.5 was associ-
ated with a 6.8% increase in mortality .
Children’s lung growth cohort studies.
Studies of chronic effects of PM exposure on
the respiratory health of children have been
conducted by two of the PM centers. Recently
reported results from the Children’s Health
Study (CHS) in southern California showed
that PM2.5 is significantly associated with
slower growth of lung function in children
residing in communities with higher than
average annual PM2.5 concentrations.
Furthermore, children who have moved from
the high PM areas into areas with lower PM
did not recover their lost lung function but
had subsequent rates of lung function growth
equal to that of the children in their new com-
munities. Children who moved from low PM
areas to communities with higher PM levels
had less lung function growth than children
who remained in the low PM areas (Avol et al.
2001). The results of these analyses have pro-
vided a basis for follow-on studies of intra-
community variations in response that are
supported by PM center funds. The focus of
these recent and future studies is on proximity
to heavily traveled express roads as an inde-
pendent risk factor.
These results have also stimulated PM
center plans for follow-up studies of the
cohorts of children from the Six Cities and
Twenty-four Cities studies. Fourth and fifth
grade children in the Twenty-four Cities
study showed lower lung function associated
with community-specific PM2.5 concentra-
tions. Many of these children have now been
retested as mature twelfth graders, and their
lung growth will be compared with commu-
nity air pollution levels as was done in the
southern California study. 
Short-Term Goals in Chronic Effects
The follow-up and data analysis on the Six
Cities and ACS study participants will con-
tinue to assess source-speciﬁc characteristics of
PM responsible for chronic mortality
(longevity reduction) effects. This will include
the assessment of individual characteristics
(disease state, socioeconomic status, smoking,
occupational exposures) that make study par-
ticipants more susceptible to effects of PM on
survival. Air pollution will be treated as a
time-dependent covariate in the Six Cities
cohort to determine how much of the associa-
tion with mortality in the prospective cohort
study is due to exposure in the past year as
opposed to over a lifetime. Estimates of the
distribution of years of life lost associated
with PM air pollution in the Six Cities cohort
will also be computed. Further studies of the
ACS cohort longevity reduction will focus on
the relationship between mortality and PM
composition and/or source contribution. This
will be accomplished by using particle specia-
tion data, both the historic dichotomous sam-
pler network data and the new speciation site
data, and source apportionment techniques.
The association between PM2.5 and/or sulfate
and local airport visibility will be determined
for each community where suitable data are
available. City-specific relationships between
pollution and visibility measurements will be
used to estimate PM2.5 levels prior to and
after the limited period for which direct mea-
surement data are available in an effort to
investigate the relative roles of past and
current exposures.
Analyses of data previously collected on
cohorts of children from studies performed by
PM center investigators (Twenty-four Cities
and southern California CHS) will be pooled
to assess effects of PM from different source
classes (e.g., vehicular vs. power plant) and
composition (e.g., nitrate vs. sulfate). Each of
these cohort studies assessed fourth and ﬁfth
grade school children using the same ques-
tionnaires and pulmonary function measure-
ments. The Twenty-four Cities study assessed
the effects of sulfate particles from coal-ﬁred
power plants. The southern California study
assessed the effects of nitrate particles from
vehicular traffic. The combined data set will
assess chronic health effects in these children
versus PM2.5 mass and composition data.
A new epidemiological study of partici-
pants in the National Heart, Lung, and Blood
Institute Women’s Health Initiative
Observational Study (93,000 women 50–79
years of age from 40 centers around the coun-
try) is currently under way. The women are
being observed for the occurrence of CVD and
will be matched with community air pollution
levels from ambient monitors. The effects of
chronic exposure to ambient PM on the inci-
dence of CVD will be assessed in this cohort
using a proportional hazards model approach.
In prior epidemiological studies in Erfurt
and Augsburg, Germany, acute effects of ultra-
fine particles on daily mortality (Wichmann
et al. 2000) and on myocardial infarction
(Peters et al. 2001) were observed. Cohorts
that were established in these cities will be used
in the future to investigate whether there are
long-term effects of exposures to ultrafine
particles.
A PM center subchronic animal inha-
lation study using New York CAPs began
in the spring of 2002. Normal and cardiac
disease–susceptible mice will be exposed for
6 hr/day, 5 days per week, for 6 months, with
or without intermittent ozone exposure.
Cardiac and respiratory function will be moni-
tored periodically, and biochemical and
genetic biomarkers of responses will be investi-
gated in tissues and lung lavage cells from the
exposed animals. In another study, mice will
undergo infectious bacterial challenge prior to
CAPs exposures to determine possible PM
exposure-related enhancement of their suscep-
tibility to infection. These studies will thereby
assess health end points being evaluated dur-
ing acute CAPs exposures of animals at several
of the PM centers and of humans at the
U.S. EPA Clinical Studies Laboratory in
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Figure 6. Mean increase and 95% conﬁdence inter-
vals for annual mortality rate increases per 10
µg/m3 increment of PM2.5 for the Six Cities and ACS
cohorts based on 16 years of mortality data.Chapel Hill, North Carolina, and determine
whether such acute effects progress to chronic
changes that could lead to enhanced suscepti-
bility to PM exposures.
Long-Term Goals in Chronic Effects
Based on previous experience, repeated follow-
up of existing cohorts can be of paramount
importance in understanding the association
between chronic PM exposures and human
health. Results from the Six Cities and
Children’s Health studies, for example, have
enabled us to understand the effects of air pol-
lution on children’s lung growth. Collectively,
the PM centers have already investigated
numerous cohorts that span ages, ethnicities,
and geographic locations and that are exposed
to varying PM levels and compositions. Health
and exposure history data for these cohorts are
also available. Information from these numer-
ous study locations will be combined to
increase the statistical power of existing chronic
health effects models. The range of data will, in
turn, allow us to better examine the role of PM
composition, gaseous co-pollutants, ethnicity,
exposure history, age, and climate on chronic
PM health effects. Therefore, it would be
advantageous for the PM centers to allocate a
large fraction of their resources during the next
5–10 years to continue with the follow-up for
these existing cohorts. 
As new scientific information emerges,
providing better indicators of air pollution
health effects, questionnaires and medical
examinations will be amended accordingly.
For example, the early cohort studies of popu-
lations initially recruited in the mid-1970s
focused on the impact of air pollution expo-
sures on respiratory health. Therefore, investi-
gations centered on collecting detailed
information on respiratory health. Recent
studies have demonstrated the influence of
particles and air quality on cardiovascular
health. Correspondingly, information on car-
diac health has assumed a more central role in
current studies. Although limited information
currently exists on the effect of air pollution
among susceptible populations, future knowl-
edge may require a better understanding of
factors predisposing these individuals to
adverse health outcomes. Of particular inter-
est is the gene–environment interaction.
Research that integrates the ﬁndings from the
CHS with new information on trafﬁc density
and the organic constituents in trafﬁc-related
PM will also be pursued as a long-term goal.
For chronic studies using CAPs-exposed
animal models, the specific hypothesis to be
addressed in future years will be based, in part,
on the findings of the first subchronic expo-
sure study to be conducted in New York. This
study will examine the possible acceleration of
atherosclerotic plaque development, increased
reactive or obstructive airway disease, reduced
lung capacities, enhanced susceptibility to
infectious agent exposures, and altered gene
expression. Moreover, efforts will be made to
determine whether variations in responses dur-
ing the exposures can be related to the day-to-
day variations in the chemical composition of
the CAPs. Based on the results from this
study, the following parameters may be con-
sidered in future chronic exposure studies:
a) including additional animal models to repli-
cate human susceptibility; b) increasing expo-
sure durations; and c) examining coexposures
to CAPs with one or more gaseous co-pollu-
tants. Of additional importance will be the
investigation of chronic health effects thresh-
olds by conducting subchronic exposure
studies at multiple PM concentrations to
determine the existence of thresholds, if any,
and replication of one or more of these studies
in areas where the PM composition is differ-
ent. Finally, we expect that the ﬁndings from
the controlled animal studies will assist in fur-
ther refining study designs for our human
chronic health effects investigations.
Dosimetry
Background
A critical link in the evaluation of the rela-
tionship between individual exposures to PM
and health responses is dosimetry. Dosimetry
research investigates not only the amounts
and distribution of the deposited PM in the
respiratory tract but also the pathways by
which this material is translocated to other
sites in both the respiratory tract and to more
distal organ systems. Furthermore, knowl-
edge of inter- and intraspecies differences is
critical to our effort to extrapolate results
from experimental studies to the population
at large. 
Prior to the establishment of the PM cen-
ters, studies of PM dosimetry in lung airways
concentrated largely on healthy adult humans,
although there were a few studies of children
and adults with chronic respiratory disease.
However, very little research has examined
deposition in animal models that are currently
being used in studies of PM health effects as
surrogates of susceptible human populations.
Mathematical deposition models derived from
experimental data had been developed and
were largely used for predicting total and
regional deposited doses. Mechanisms for
clearance of deposited particles had also been
studied, and major clearance pathways in the
respiratory tract regions had been well
described. However, several major gaps in our
understanding of particle deposition and clear-
ance remained, including detailed analyses of
size-resolved PM deposition and clearance,
especially for ultraﬁne particles, and clearance
mechanisms for PM components as well as
their translocation pathways.
Research addressing these gaps is important
for the interpretation of toxicological and epi-
demiological ﬁndings suggesting effects on car-
diopulmonary systems, which could be due to
indirect (via biological mediators initiated from
acute pulmonary effects) or direct or neuronal
function changes. The multidisciplinary teams
of PM centers investigators provides a great
advantage in addressing these questions.
Progress Made in Dosimetry
Significant advances have been made at the
PM centers in a number of critical areas. These
include development of techniques for the pro-
duction of hollow lung airway casts of poten-
tially susceptible people and evaluation of
dosimetry of speciﬁc fractions of ambient PM
that may be especially toxic. There has also
been work on dosimetry in humans and in ani-
mal models being used in PM studies, using
both ambient PM and surrogate particles.
To address the paucity of data regarding
PM deposition in the lungs of people with
preexisting pulmonary disease, a pilot PM
center project investigated the potential for
retrieval of morphometric data from three-
dimensional images of tracheobronchial air-
ways obtained in vivo by X-ray computerized
tomography (CT). The study also explored
the potential for the use of stereolithography
(STL) to produce hollow airway casts of nor-
mal and abnormal lung airways for the deter-
mination of site-specific deposition and for
experimental veriﬁcation of particle deposition
models. A volumetric rendering of the interior
surface of a hollow airway cast (used in previ-
ous studies) was generated, producing a sur-
face representation of the airway tree. These
three-dimensional images were then converted
to an STL file format required for the rapid
prototyping of airway casts. The STL unit uses
a computer-controlled arm connected to a
plastic extrusion device to build volumetric
structures layer by layer. Figure 7 demon-
strates the close concordance between an origi-
nal hollow airway cast and the replicate made
of it by STL (Won et al. 2000a, 2000b).
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Figure 7. Cross-sectional luminal airway surface of
original hollow airway cast made from a normal
human tracheobronchial tree in square millimeters
versus corresponding airway surface in square
millimeters of a replica produced by STL using data
obtained by CT scanning of the original cast.Thin, multislice, helical CT scanning
allows for the acquisition of high-resolution
volumetric image data sets of the lung during a
breath-hold, or at multiple phases within a res-
piratory cycle for children, the elderly, and peo-
ple of all ages having asthma or chronic
obstructive lung disease. From these scans, hol-
low airway casts that include five or six
bronchial generations can be created and repli-
cated for use in studies of inhaled particle depo-
sition in replicate casts of both healthy and
diseased airways, using realistic air ﬂow rates. 
In another study, PM center methodology
was developed to determine total lung deposi-
tion of CAPs in dogs. These studies are rele-
vant to animal models of cardiac disease used
in the PM center research. The methods
included the use of a breath-by-breath respira-
tory monitoring system that provided both rate
and tidal volume as well as measurement of
inhaled and exhaled particle number, classiﬁed
by size. These measurements used both a TSI
Scanning Mobility Particle Sizer for particles in
the ultraﬁne and smaller ﬁne ranges, and a TSI
Aerosizer (TSI, Inc., Shoreview, MN) for parti-
cles in the ﬁne particle size range. The canine
studies showed deposition of ambient particles
followed a pattern similar to that described in
the International Commission on Radiological
Protection (ICRP) human particle deposition
model (ICRP 1994) but was slightly greater
than that predicted by the ICRP model. This
method was subsequently used in a study of six
human subjects breathing ambient air without
any enhancement of particle concentration. In
all subjects, total respiratory deposition fraction
(DF) for each measured size range (> 10 nm)
followed the same pattern predicted by the
ICRP model, and in some individuals, deposi-
tion exceeded the predicted fraction. Human
studies of ambient particle deposition are
important to validate deposition models.
In vivo deposition studies of ultrafine
particles are currently being conducted in
humans and rats. For the human studies, a
system was developed for mouthpiece expo-
sures, with alternating rest and exercise every
15 min. Total respiratory DFs for particle
number and mass were determined down to
7-nm particles. Ultrafine carbon particles
(22 nm) were generated. Eleven nonsmok-
ing, healthy subjects and 11 nonsmoking
subjects with mild asthma were exposed for
2 hr. The total respiratory deposition of
inhaled ultrafine particles was high relative
to fine particles in healthy subjects (DF =
0.63 ± 0.03), and was further increased dur-
ing exercise (DF = 0.83 ± 0.04), with
enhanced deposition in asthmatics (rest DF
= 0.77 ± 0.05; exercise DF = 0.86 ± 0.04).
These results suggest that asthmatics may be
at greater risk from exposure to ultraﬁne par-
ticles because of increased deposition in
central airways.
Deposition rates for size-resolved ultraﬁne
particle data showed that 7-nm particles had
the highest total deposition (~ 80%).
Deposition efﬁciency (DE) for 100-nm parti-
cles was ~ 45%. These deposition rates are in
good agreement with the ICRP particle depo-
sition model (ICRP 1994). This model pre-
dicts that ambient ultraﬁne particles of 20 nm
will have the highest overall DE, as well as the
highest deposition in the gas-exchange region
(Chalupa et al. 2002a, 2000b; Daigle et al.
2003; Frampton et al. 2000).
Experiments in rats were performed using
two types of ultraﬁne 192Ir particles and car-
bon particles containing the stable isotope
13C particles. The basic design of both rat
studies was the same, i.e., exposure to the
ultrafine particles followed by serial sacrifice
in the postexposure period and analysis of
excised lungs and extrapulmonary organs for
13C and 192Ir, respectively. However, there
were major differences. The 13C exposure
occurred for 6 hr in compartmentalized
whole-body exposure chambers, whereas the
192Ir exposures occurred via a 1-hr intra-
tracheal inhalation in anesthetized rats.
For the 13C exposures, the median
particle size was in the range of 20–29 nm.
Exposure concentrations ranged from 80 to
180 µg/m3, and organ burdens were deter-
mined in the ﬁrst series of experiments at 0.5,
18, and 24 hr after exposure. Six unexposed
rats served as controls. Lung lobes, liver,
heart, kidney, and brain sections (olfactory,
cerebrum, cerebellum) were analyzed for 13C
by isotope ratio mass spectrometry (MS). On
average, approximately 9 ng 13C/g lung per
µg/m3 of exposure was found in the lung,
much less than expected based on predictive
lung deposition models. Signiﬁcant amounts
of 13C had accumulated in the liver by 0.5 hr
postinhalation only at the high exposure con-
centration of 180 µg/m3, whereas by 18 and
24 hr postexposure, all liver samples showed
significantly increased 13C. Indeed, the
amount of total 13C in the liver at those time
points exceeded the amount retained in the
lung, demonstrating a fast translocation of
ultrafine carbon particles to the liver. Other
extrapulmonary organs analyzed for 13C did
not show signiﬁcant increases by 24 hr post-
exposure (Oberdörster et al. 2002).
Results were different for ultrafine Ir
particles. Ir was found, in pretest studies, to
be essentially insoluble. In these studies, the
median particle size was approximately 15
nm. Gamma-spectroscopic analysis for 192Ir
was performed at time points ranging from
6 hr to 7 days postexposure. The ultrafine
192Ir particles, after an initial fast tracheo-
bronchial clearance, were essentially retained
in the lung; only minute amounts were found
in extrapulmonary tissues [~ 0.5% in bone
and soft tissue (muscle), < 0.1% in liver, and
even less in heart and brain]. Soluble Ir was
excreted via urine (60% over 7 days), 8%
remained in the lungs, and 10% was retained
in both soft tissue and bone (Kreyling et al.
2002). These results show that translocation
of poorly soluble ultrafine particles to extra-
pulmonary sites appears to be highly depen-
dent on the chemical nature of the particles.
Carbon particles were to a large degree
translocated to the liver, whereas metal irid-
ium particles were not. These results raise a
number of questions that need to be
addressed in future studies, including the
evaluation of pathways for ultrafine particle
translocation (lymphatic, blood vessels, gas-
trointestinal tract, nasal vs. tracheobronchial
vs. alveolar region) and also binding of ultra-
ﬁnes to proteins.
Because currently available inhaled parti-
cle dose models provide estimates of averaged
doses (i.e., environmental aerosol concentra-
tions), they do not take into account the true
PM heterogeneity of tissue doses that occur
in the lungs. Higher-than-average doses can
be expected for those people exposed near
local particle sources, those who have high
specific ventilations (ratio of air intake to
body mass), and those who have heteroge-
neous deposition of particles within various
regions of the respiratory tract. Thus, exercis-
ing adults and children with lung diseases
who live near heavily used freeways may be
receiving greatly elevated particle doses at
numerous sites within their lungs. Similarly,
the available software used for computing
inhaled particle deposition cannot identify
local populations of cells that may be of toxi-
cological interest. The numbers of cells that
must be significantly damaged to seriously
impact vulnerable individuals is not yet
known. These issues were addressed by a PM
center workshop in October 2001 that devel-
oped a framework for estimating expected
local tissue dose concentrations. This frame-
work was applied to southern California
Supersite data sets, and local doses to sites
containing the highest exposed 100 cells at
each bifurcation in the tracheobronchial tree
were calculated for heavily exposed individu-
als. These local bifurcation area doses were
compared with the doses applied to cells in
in vitro studies of PM effects. The high in
vitro doses corresponded to estimated airway
bifurcation PM doses potentially occurring in
the lungs of individuals living in the
Los Angeles basin.
Short-Term Goals in Dosimetry
In a successor project to the pilot feasibility
study for the production of hollow airway
casts that faithfully reproduce the in vivo
dimensions, in vivo studies are being con-
ducted of particle deposition in anesthetized
sheep at the facilities of study collaborators at
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using 5-µm diameter radio-opaque droplets.
This involves development of analytical pro-
grams to examine the CT scan data. The sec-
ond phase will be to examine changes in the
deposition pattern and efﬁciency when inhala-
tion is done at different points of the inspira-
tory cycle. The computer-controlled respirator
can produce almost any breathing pattern and
can key the aerosol delivery to any point in the
respiratory cycle of the anesthetized sheep.
When quantitation has been accomplished in
vivo, hollow airway casts of the sheep lung will
be produced using the methods developed in
the initial PM center pilot study. PM deposi-
tion patterns and efficiencies will then be
determined using an artificial thorax and
methods and models previously used at NYU
to measure particle deposition in the hollow-
cast systems. Successful development of the
test aerosol as well as quantitation methods
will ultimately allow future exploitation of
these techniques for in vivo studies in both
healthy people and those with compromised
lung function. In addition to determining DE
and pattern studies, PM center studies will
explore the potential for identifying bolus
deposition in the sheep lung and the extent to
which assumptions of standard bolus deposi-
tion experiments are valid. The system will
allow testing of the hypothesis proposed by C.
Kim and colleagues at the U.S. EPA—that
regional deposition can be accurately assessed
in people via a series of bolus inhalation exper-
iments (Kim 2000).
Other PM center dosimetry studies will
continue to focus on ambient particles and
their diurnal and temporal variation in con-
centration and composition. The number of
subjects will be expanded as well as the num-
ber of repetitions per subject. This will permit
definition of the range of individual differ-
ences in particle DFs, including male–female
and age differences. In addition, the relation-
ship of DF to day-to-day compositional dif-
ferences will be explored to determine the
factors important in variations in DF.
Research will continue on ultraﬁne particle
deposition, disposition, and chemistry.
Investigations will include the continued study
of susceptible groups (e.g., COPD, elderly) in
terms of total respiratory tract deposition; the
effects of changes in tidal volume and respira-
tory rate in deposition; deposition efﬁciencies
in different anatomical compartments of the
respiratory tract; clearance and translocation
pathways via the respiratory and gastrointesti-
nal tracts; translocation following the initial
phase of accumulation in the liver; the liver as
a storage organ for distribution to other
organs; the mechanisms of particle transloca-
tion; the role of particle chemistry; the fate of
organic carbon particles; the efficiency of
ultrafine particle translocation along sensory
nerves in the conducting airways; and the
long-term consequences of ultrafine particle
translocation to extrapulmonary organs like
the heart.
Answers to these questions are important
for the interpretation of results of toxicologi-
cal and epidemiological studies with respect
to effects of inhaled particles on the cardiovas-
cular system that could be due to indirect (via
biological mediators initiated from acute pul-
monary effects) or direct (ultrafine particles
interacting with cardiac or endothelial cells)
or neuronal functions effects. 
To better understand the generalizability
of controlled animal PM exposures to human
health, the regional inhaled particle deposi-
tions in mice from the freeway study will be
determined. Toward this end, replica airway
casts of 30 Balb/c mice (15 controls and 15
sensitized) will be prepared, and morphomet-
ric measurements of airways will be con-
ducted. The mice will be exposed to three
sizes of electrically discharged fluorescent
monodisperse polystyrene latex particles.
Their lungs will be digested, and particles
deposited in the lungs will be recovered and
counted using a ﬂuorescence-equipped micro-
scope. These measurements will be used for
examining the toxicologic responses of the
sensitized model, as well as for performing
extrapolations to humans. 
Long-Term Goals in Dosimetry
The results of the in vivo particle deposition
studies in sheep will provide a ﬁrm basis for a
study of human subjects. The future human
in vivo studies will focus on a) application of
accepted mathematical dosimetry models to
individuals, using the morphometric data
retrieved from the images. This will be
assisted by respiratory function test results
that will be available for these individuals;
b) measurement of detailed particle deposi-
tion data for a range of breathing patterns and
particle sizes in hollow-cast models of the air-
ways of individuals representative of the vari-
ous groups of interest; and c) reconciliation of
the results calculated from the current models
with experimental data to produce verified
empirical deposition models that can be used
to better predict inhaled dose on the basis of
metrics of exposure to ambient PM.
Future research to relate airborne PM to
improved dosimetric models will be directed
toward deﬁning the population receiving the
highest local doses in their tissues, and deﬁning
the appropriate particle doses for use in in vitro
mechanistic studies. Research is also needed to
address a) the environmental heterogeneity of
PM-associated pollutants; b) how much time
susceptible subpopulations spend in such high-
concentration areas; c) ventilation rates of those
exposed; d) heterogeneous deposition patterns
of inhaled particles; e) dose implications of
impaired clearance (as is seen in some disease
states) and sequestration of particle associated
substances; f ) vulnerable target cells in the tis-
sues; and g) realistic target particle doses that
can be used for the design and interpretation of
in vitro mechanistic research.
Exposure Assessment
Background
As noted in the section “Acute Health Effects
of Particulate Matter,” results from daily mor-
tality and morbidity time-series analyses pro-
vided much of the scientific basis for setting
the PM standards in 1997. These epidemio-
logical studies typically used PM mass con-
centrations measured at outdoor monitoring
sites as surrogates of population exposures to
ambient air PM. The extent to which outdoor
measurements accurately reflect PM expo-
sures has been the subject of considerable
scientiﬁc debate. Results from early exposure
studies, such as those conducted as part of
the Harvard Six Cities Study and the U.S.
EPA Particle Total Exposure Assessment
Methodology Study (Clayton et al. 1993), for
example, suggested that personal PM expo-
sures may differ substantially from outdoor
concentrations because of contributions from
indoor sources. Cross-sectional analyses of
these data showed weak associations between
daily outdoor PM concentrations and corre-
sponding personal exposures, which were
attributed to intersubject variability and the
limited number of measurements (~ 1–2
days) for each individual. Consequently, the
existing PM exposure database was considered
inadequate for investigating associations
between personal exposures and outdoor con-
centrations, and longitudinal exposure studies
were proposed. 
Upon completion of the 1997 PM
NAAQS review and prior to the establishment
of the ﬁve PM centers, a series of longitudinal
PM exposure studies were funded by the U.S.
EPA, HEI, Electric Power Research Institute,
U.S. Department of Energy, and American
Petroleum Institute. The main objective of
these studies was to investigate associations
over time between personal PM exposures and
outdoor PM concentrations, with specific
focus on characterizing exposures for individu-
als thought to be especially susceptible to PM-
associated health effects. U.S. EPA-sponsored
research projects were conducted by groups
from Harvard University, NYU, and the
University of Washington. The three research
groups collaborated closely in the design and
preparation of ﬁeld studies and shared similar
sampling procedures and questionnaires in an
effort to create compatible data sets. As part of
these early longitudinal studies, the exposures
of several cohorts of susceptible individuals,
including senior citizens, children, and
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measured for periods ranging from 1 to 2
weeks. Field studies were conducted during
both the summer and winter and in a variety
of urban and suburban environments includ-
ing Atlanta, Georgia; Baltimore, Maryland;
Boston, Massachusetts; Nashville, Tennessee;
New York, New York; and Seattle,
Washington. Although analyses of the entire
body of data are still in progress, several papers
have been published and have been cited in
the 2001 PM Criteria Document external-
review draft. The U.S. EPA Ofﬁce of Research
and Development is planning to use this rich
database to develop both acute and chronic
exposure models.
A major finding of these studies is that
stronger personal-outdoor PM correlations
exist when data are analyzed by individual,
over time. However, the degree of this associ-
ation varies by individual, with some individ-
uals having signiﬁcant associations and others
not. A major deficiency in exposure assess-
ment research, which still persists, relates to
the lack of accurate chronic exposure models
to be used by epidemiological studies. 
Progress Made in Exposure
Assessment
The ﬁndings from the longitudinal PM expo-
sure studies, described above, were critical to
the evolution of our collective research efforts
on PM exposure assessment. Results from the
centers research pertaining to PM exposures
are presented brieﬂy below, with many of the
ﬁndings already published, in press, or submit-
ted for publication in peer-reviewed journals. 
Considerable research was conducted to
identify factors that contribute to observed
differences between outdoor concentrations
of PM and corresponding population expo-
sures. The differences have traditionally been
referred to as “exposure error” because PM
epidemiological studies typically use outdoor
PM concentrations as surrogates of exposure.
PM centers exposure research efforts have
focused on the following topics: 
• Characterization of spatio-temporal variabil-
ity of PM components and gaseous co-pol-
lutants measured at centrally located
outdoor sites as a function of site character-
istics using the entire U.S. air monitoring
network. The models will enable epidemiol-
ogists to quantify the effects of exposure
error on health risk estimates. 
• Assessment of the contribution of outdoor
and indoor PM sources on personal expo-
sures. This area of research is critical for
determining the relative toxicities of PM of
outdoor and indoor origin. 
• Measurement of exposure to specific toxic
PM components and gaseous co-pollutants.
This information will be of great value to
epidemiologists and toxicologists in their
efforts to identify the causal agents of air
pollution–related toxicity.
Investigation of the association between
outdoor particulate matter concentrations and
corresponding personal exposures. Ambient
PM2.5 concentrations were signiﬁcant predic-
tors of corresponding personal exposures over
time for a cohort of healthy senior citizens
(Figure 8) (Sarnat et al. 2000). Although the
strength of these associations varied by indi-
vidual and season, the results suggest that for
certain individuals, ambient PM2.5 concentra-
tions are appropriate surrogates of personal
PM2.5 exposures. These ﬁndings are consistent
with results from recent longitudinal PM
exposure studies conducted in Boston (Rojas-
Bracho et al. 2000) and the Netherlands
(Janssen et al. 1998). When the subject-spe-
cific data were aggregated and analyzed
together (i.e., cross-sectionally), the association
between personal exposures and outdoor con-
centration was weaker, further highlighting
the inadequacy of cross-sectional analytical
methods for assessing true personal-ambient
PM2.5 associations for time-series studies. 
Because most of these subjects spent the
majority of their time (> 95%) indoors during
both seasons, seasonal differences in personal-
ambient associations were likely due to changes
in indoor ventilation conditions between the
summer and winter. Summertime records of
open window status provided direct evidence
of the effect of indoor ventilation on personal-
ambient PM2.5 associations, with ambient con-
centrations shown to be strong predictors of
corresponding personal exposures for subjects
who spent the majority of their time in well-
ventilated indoor environments. This was illus-
trated in the plot of personal PM2.5 exposures
on ambient PM2.5 concentrations, which had a
slope that was close to 1 and a limited amount
of scatter. Personal-ambient PM2.5 associations
were also signiﬁcant for subjects who spent the
majority of their time in poorly ventilated
indoor environments, but the association was
much weaker. The plot of personal exposures
on ambient concentrations for poorly venti-
lated environments had a slope well below 1,
with a considerable amount of scatter due to
the influence of poor ventilation on both
reducing the penetration efﬁciencies of ambi-
ent particles and increasing the contribution of
indoor source particles on personal exposures.
Spatial variability of outdoor particulate
matter concentrations. Some of the interper-
sonal differences in personal-outdoor PM asso-
ciations may be due to the spatial variability in
outdoor PM concentrations. Ito et al. (2001)
used nationwide PM10 and gaseous pollutant
measurements to examine relationships
between concentration measured at various
urban and suburban sites. Figure 9 shows a
smoothed monitor-to-monitor temporal corre-
lation for air pollution and weather variables as
a function of distance in seven northern and
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Figure 8. Distribution of subject-specific correla-
tion coefﬁcients: ambient PM2.5 concentration ver-
sus personal PM2.5 exposures in Baltimore,
Maryland, 1998–1999. n = 14 for both sampling sea-
sons (Sarnat et al. 2000). These box plots show
median values and the 25th and 75th percentiles.
The vertical lines extend to the 10th and 90th per-
centiles and the circles indicate extreme values.  Figure 9. Smoothed monitor-to-monitor temporal correlation in seven north-central U.S. sites.central U.S. states. As shown, monitor-to-mon-
itor correlations varied by pollutant. Stronger
spatial correlations were found for PM10, NO2,
and O3 compared with those found for CO
and SO2. PM2.5 data will be incorporated
within this analysis as it becomes available. 
Previous studies in the Northeastern
United States have shown that mean daily
PM2.5 concentrations are reasonably uniform
within large Eastern U.S. metropolitan areas
such as Washington, DC, Philadelphia, and
Baltimore. Findings from PM center-sup-
ported studies further indicate that there is
relatively little variation in ambient PM2.5
concentrations between the center of New
York City and a rural upwind location
(Figure 10). Together, these results suggest
that most of the PM2.5 in the Northeastern
United States originates from distant upwind
sources (Thurston et al. Unpublished data).
However, this may not be the case in other
locations in the United States. PM2.5 mass
concentrations in Seattle exhibited modest,
yet significant, spatial variability within a
radius of 20 km. These differences were asso-
ciated with both proximity to major highways
and the elevation of the monitoring location
(Goswami et al. 2002). In Los Angeles, PM2.5
and PM10 concentrations measured at various
distances from highways (10–1,000 meters)
showed little spatial variability. However, par-
ticle number and black carbon concentrations
decreased rapidly with distance from high-
ways (Zhu et al. 2002) (Figure 11). 
The spatial variability of reactive chemical
species in PM2.5, such as quinones and their
precursors in the Los Angeles basin, showed
considerable variability from west to east,
reflecting the direction of the prevailing
winds. The naphthoquinones decreased, but
the concentration of 9,10-phenanthro-
quinone increased. As quinones are known to
be toxic, their concentrations in PM fractions
may be a more sensitive measure of exposure.
Levels of quinones in the outlying areas were,
as expected, extremely low.
Impact of indoor particulate matter
sources on personal exposures. As shown in the
earlier cross-sectional PM exposure studies,
variability in personal-outdoor PM associa-
tions is due, in part, to contributions from
nonambient particle sources (Ozkaynak et al.
1996). PM center–supported longitudinal
exposure studies have provided additional evi-
dence of the impact of non–outdoor PM
sources for both cohorts of healthy individuals
and susceptible subpopulations. Results from
Seattle and Baltimore showed that nonambi-
ent PM2.5 sources contributed 49 and 67% of
the total personal PM2.5 exposures, respec-
tively (Allen et al. 2002; Sarnat et al. 2000). In
Seattle the pediatric subjects experienced sig-
nificantly higher exposures to particles of
indoor origin than did adults. Their average
fraction of ambient PM contribution to total
human exposures was no higher, however
(Allen et al. 2002). In Baltimore, indoor
ventilation inﬂuenced nonambient PM contri-
butions to personal exposures, where non-
ambient PM2.5 sources contributed 29, 30,
and 45% to total personal PM2.5 exposures for
subjects spending their time in well-ventilated,
moderately ventilated, and poorly ventilated
indoor environments, respectively. 
Variability of outdoor particulate matter
penetration efficiencies. People spend the
majority of their time indoors. Therefore,
quantifying the effective penetration efﬁciencies
of outdoor particles into indoor environments
is critical for understanding the variability of
personal-outdoor PM relationships. Until
recently, particle penetration efﬁciencies were
thought to be constant and were often assumed
to be 100%. As a result, personal/outdoor con-
centration ratios higher than one were assumed
to be indicative of the inﬂuence from non–out-
door PM sources. Results from current PM
center exposure studies have shown that particle
penetration efﬁciencies vary substantially by res-
idence type (Larson et al. 2001). In Seattle for
example, particle penetration efﬁciency exhib-
ited significant interhome and intrahome
variability for the 30 homes monitored. Because
home characteristics, including ventilation, vary
by season and locale, these findings may be
used to explain some of the heterogeneity in
PM-associated risk factors in various epidemio-
logical studies, as reported in the section “Acute
Health Effects of Particulate Matter.”
Measurement of personal exposures to
specific toxic particulate matter components.
Identifying the speciﬁc component(s) of out-
door PM responsible for the numerous
observed adverse health effects remains an
important objective of our exposure assess-
ment research. Results presented in “Biological
Mechanisms for Particulate Matter Health
Effects” of this review suggest that specific
components of outdoor PM, such as transi-
tion metals, ultrafine particles, and PAHs,
may be related to allergic airway disease and
cardiovascular effects. 
Funding has facilitated the development
of novel personal multiple pollutant sampling
methods currently being used in many of the
PM center field studies (Figure 12)
(Demokritou et al. 2001). The Multiple
Pollutant Personal Sampler provides data on
concurrent size- and species-resolved personal
PM exposures as well as exposures to numer-
ous gaseous co-pollutants (NO2, O3, SO2,
and numerous VOCs). To date, the Multiple
Pollutant Personal Sampler has been used in
the Baltimore; Atlanta; Steubenville, Ohio;
and Los Angeles ﬁeld studies. Other methods
are currently under development at the PM
centers to examine exposures to specific PM
components.
The PM centers are conducting a series of
studies to identify and quantify speciﬁc toxic
PM components as well as examine their spa-
tial and temporal distributions. Organic PM
constituents such as quinones may play a
particularly important role in generating
oxidative stress, inﬂammation, and immuno-
modulating effects in the lungs and airways.
Currently, PM seasonal and spatial distribu-
tions of outdoor PAH, aldehyde, and quinone
concentrations are being characterized for 12
southern California communities participat-
ing in the CHS (Cho et al. Unpublished
data). Center investigators expect to link spa-
tial intercommunity variability of specific
organic (i.e., quinones) and carbonyl concen-
trations with reported respiratory health
effects of school children. 
Measurement of personal exposures to
gaseous co-pollutants. Ambient concentrations
of PM and its gaseous co-pollutants are fre-
quently correlated, making it difﬁcult for epi-
demiological investigations to determine
whether observed PM-health effect associa-
tions are confounded by these co-pollutants.
The role of gaseous co-pollutants as potential
confounders or surrogates of personal PM2.5
exposures was investigated for cohorts of
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Figure 10. Most NYC summer PM2.5 mass at health
center (in Manhattan) is explained by regional
PM2.5 at Sterling Forest, a state park northwest of
Manhattan. y = 0.9895x + 3.1262; R2 = 0.843.
Figure 11. Relative PM2.5 mass [measured by
DataRam nephelometer (MIE, Inc., Bedford, MA)],
particle number (measured by CPC), black carbon
(BC), and carbon monoxide (CO) concentrations
versus downwind distance from the Los Angeles
405 freeway (Zhu et al. 2002).healthy senior citizens, children, and individu-
als with COPD living in Baltimore (Sarnat
et al. 2001). Investigators used the Multiple-
Pollutant Personal Sampler, which allowed for
associations between personal particulate and
gaseous exposures to be examined directly.
Consistent with results from previous moni-
toring studies, strong correlations existed
between ambient PM2.5 and personal gaseous
co-pollutant concentrations (i.e., O3, NO2)
(Figure 13). In contrast, weak correlations
were found between personal PM2.5 and per-
sonal gaseous co-pollutant exposures, suggest-
ing that the gaseous co-pollutants are unlikely
confounders of PM2.5. Finally, strong correla-
tions between personal exposures to PM2.5
and ambient concentrations of the co-pollu-
tants existed, indicating that the gaseous co-
pollutants may serve as appropriate surrogates
of personal PM2.5 exposures. 
Short-Term Goals in Exposure
Assessment
Exposure studies conducted to date have
provided a solid basis for future research.
Goals of the PM centers during the next 2–3
years include the following:
• Complete exposure studies currently being
conducted in St. Louis, Los Angeles,
Steubenville, and Seattle. These additional
data sets will enable us to further character-
ize personal PM exposures in locations with
diverse study populations and meteorologi-
cal and air quality conditions. Of particular
importance are potential differences in
exposures among susceptible subpopula-
tions. To date, cohort-speciﬁc differences in
PM exposures have not been examined
because of sample-size limitations.
• Examine associations between personal expo-
sures to PM and its gaseous co-pollutants in
various locations throughout the United
States. Results from Baltimore provide impor-
tant initial information concerning the role of
gaseous pollutants as confounders and/or sur-
rogates of PM. Exposure data from studies in
Los Angeles, Atlanta, Steubenville, and
St. Louis will enable us to examine these rela-
tionships in additional urban environments.
• Continue the characterization of short-term
(24-hr) PM exposures and identify factors
that inﬂuence their relationship to outdoor
concentrations. This information will assist
in creating models of short-term personal
exposures to be used in estimating chronic
exposures to PM.
• Collect data on outdoor PM concentrations
and personal exposures to speciﬁc PM com-
ponents such as metals, PAHs, elemental and
organic carbon, sulfate, and nitrate as part of
our ongoing ﬁeld studies. In addition, efforts
will continue to expand the range of personal
exposure measurements, including ultraﬁne
particles and carbon monoxide.
• Determine concentrations of quinones, car-
bonyls, and PAHs in ambient air samples at
selected sites in the Los Angeles basin. The
objective is to provide quantitative chemical
data on speciﬁc chemical entities relevant to
human health and to the development of a
model for atmospheric changes in the chemi-
cal constituents of air pollution.
• Continue data analyses for the investigation
of exposure error using air pollution data
from 1985 to 2000 for the entire United
States. More detailed characterization and
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Figure 12. Diagram of the multipollutant personal sampler (Demokritou et al. 2001). Abbreviations: EC, ele-
mental carbon; MSC, mini personal sampler; MSD, mini denuder; OC, organic carbon; SPM, suspended
particulate matter.
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Figure 13. Summary of associations between ambient concentrations and corresponding personal expo-
sures and among pollutant exposures and concentrations in Baltimore, Maryland (Sarnat et al. 2001). “✓”
indicates strong correlations; “×” indicates weak correlations.comparison of PM10 and PM2.5 data will be
conducted in areas with multiple monitors.
• Continue collection of outdoor PM samples
to be used in toxicological studies of ﬁne and
ultraﬁne ambient particles. Initial studies to
examine the hypothesis that freshly generated
ﬁne plus ultraﬁne emissions from a freeway
with heavy diesel trafﬁc increases the severity
of asthma and inﬂammatory responses in a
sensitive animal model are under way.
• Validate and reﬁne models of local within-
community exposures based on already
available data sets on trafﬁc patterns in met-
ropolitan areas and further assessment of the
chemical composition of traffic-associated
particulate exposures.
Long-Term Goals in Exposure
Assessment
The PM centers’ long-term goals involving
exposure assessment include the following:
a) Development of chronic PM exposure mod-
els. Chronic exposure models will be based on
relevant advances in short-term exposure mod-
els, reexaminations of historical and newly gen-
erated data on air pollution composition and
levels, time–activity information, and indirect
measures of PM exposure, such as covarying
gaseous pollutant concentrations; geographical
information system data, and housing charac-
teristics may also be used as input data for
these chronic exposure models. Individual or
population estimates of long-term exposures
will be used by epidemiological studies to assess
chronic health effects. Of particular impor-
tance will be the development of chronic expo-
sure models for speciﬁc toxic components of
PM. b) Development and validation of source-
apportionment techniques to link health out-
comes with specific PM source types. The
NYU PM center in collaboration with col-
leagues at the other PM centers and at the U.S.
EPA will host a source apportionment work-
shop to standardize source-apportionment
methodologies for PM epidemiological studies.
c) Development of new and more sensitive bio-
markers of PM exposure. This will enable us to
assess human exposures for prospective popula-
tion studies in a timely and cost-effective man-
ner. Some preliminary work on a urinary
biomarker for exposure to wood smoke is under
way (Dills et al. 2001).
Coordination of Research
within the Particulate Matter
Centers Program
Background
Research centers are most productive where
there is a well-defined set of scientific ques-
tions, and where the approaches needed to
answer those questions cross traditional disci-
plinary boundaries of chemists, engineers,
aerosol scientists, toxicologists, epidemiologists,
pulmonologists, cardiologists, immunologists,
molecular biologists, statisticians, and experts
in exposure and risk assessment. 
Going beyond what individual centers
can accomplish, the U.S. EPA–sponsored PM
Health Effects Research centers, with encour-
agement from the U.S. EPA, have created a
coordinated PM centers program that keeps
each center aware of work in progress and
plans for the other centers, enabling them to
more fully address the critical knowledge gaps
confronting the U.S. EPA.
Linking the activities of the ﬁve PM cen-
ters and the U.S. EPA labs on a conceptual and
operational basis to maximize productivity and
relevance of the scientiﬁc ﬁndings represents a
new direction for university-based research,
with long-term signiﬁcance. For example, for
biological mechanisms, investigators from all
five PM centers participated in discussions
about unifying hypotheses of biological mecha-
nisms for PM health effects, which include
inﬂammation and immunity, mechanisms for
cardiovascular effects, and the role of ROS. 
There are other valuable features of the
PM centers programs.
• Acceleration of the research process. In a
rapidly evolving ﬁeld such as PM research,
investigators need to initiate new projects
that may have a significant impact on the
field. Conducting hypothesis-generating
studies can be of paramount importance.
The PM centers program has used pilot
project funds to expedite the process of con-
ducting exploratory research.
• Use of science advisory committees. The PM
centers have effectively used groups of experts
to oversee their research programs, and most
of the PM centers’ external science advisory
committees include researchers from other
PM centers. This has helped to coordinate
research efforts among the PM centers, avoid
duplication, and share resources. 
• Leveraging funds to start new research ini-
tiatives. The PM centers can provide seed
funds for future research initiatives and cre-
ate opportunities for young investigators to
be integrated into the overall research of the
PM centers. 
• Development of new technologies. The PM
centers have the resources to develop com-
plex new technologies that are available to
the individuals in PM centers as well as to
other affiliated research groups. The cre-
ation of the new ultraﬁne concentrator and
multipollutant sampler are examples of
innovative technology that derived from the
creation of the PM centers. Oversight of the
application of new technologies across the
PM centers facilitates their validation and
optimal utilization. 
• Flexibility to reallocate funds as needed and
to change research direction. The PM centers
have sometimes been faced with unexpected
research opportunities and/or expenses. On
the basis of the input from their science
advisory committees, the PM centers can
reduce or expand activities in certain projects
in favor of others.
Particulate Matter Center Strengths
Each of the PM centers has particular
strengths, as outlined below.
Strengths of the NYU PM center include a
capacity to conduct studies of the acute and
cumulative effects of concentrated ambient air
particles on cardiac and respiratory system
effects in laboratory animals; a focus on particle
dosimetry in the respiratory tract in both nor-
mal and abnormal human lungs; capabilities
for the generation of exposure atmospheres of
freshly formed ultraﬁne and ﬁne monodisperse
aerosols of acid aerosols, elemental and organic
particles, and metal oxides; and an array of
inhalation chambers and head-only exposure
chambers for controlled exposure studies. 
Strengths of the Rochester PM center
include an interdisciplinary approach in ambi-
ent characterization studies, epidemiological
studies, clinical studies, animal studies, and
in vitro mechanistic studies; a focus on the role
of ultraﬁne particles compared with other parti-
cle-size fractions; and experience in performing
studies using laboratory-generated surrogate
particles as well as real-world particles. 
Strengths of the southern California PM
center include a well-deﬁned focus on mobile
source pollution and health effects, with
emphasis on investigation of the biological
mechanisms of PM effects in relation to PM
characteristics; emission sources and related
adverse health effects; and the varying spatial
and temporal patterns of ambient PM and co-
pollutants and resulting health effects, with
emphasis on ﬁeld measurements and modeling.
Other strengths include the uniqueness of
the Los Angeles basin airshed and close inter-
action with the Los Angeles Supersite; exper-
tise from ﬁve leading universities in the region
as well as the University of California Davis
(Davis, California) and Michigan State
University (East Lansing, Michigan); exten-
sive ties with the CHS; the availability of
mobile ultrafine, fine, and coarse concentra-
tors for sample collection and in vivo animal
and human clinical studies; and a focus on
ROS acting as electrophilic agents and play-
ing a central role in allergic airway disease
including asthma and cardiovascular effects
through their ability to generate oxidative
stress, inﬂammation, and immunomodulating
effects in the lungs and airways.
Strengths of the University of Washington
PM center include experience in exposure
assessment; experience in studies of acute
health effects; a mouse model of CVD; a new
chronic cohort mortality study (the Women’s
Health Initiative); and access to an airshed in
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common to the east and with a higher contri-
bution from vegetative burning.
Strengths of the Harvard PM center
include close interaction among biological, epi-
demiological, exposure, and engineering
research groups, which has led to the develop-
ment of sensitive animal models based on our
epidemiology studies—in turn, the controlled
toxicology studies have developed reﬁned out-
comes that are currently being used in epi-
demiological and exposure group studies
(Steubenville and St. Louis); experience in con-
ducting panel studies examining the relation-
ships between outdoor and indoor PM
concentrations and corresponding personal
exposures; development of statistical models
for use in time-series analyses addressing har-
vesting, confounding, and dose–response rela-
tionships; a focus on methods development for
measuring continuous sulfate and nitrate con-
centrations, personal particulate, and gaseous
exposures; a PM concentrator for coarse, ﬁne
and ultraﬁne particle modes; and development
of novel inhalation technologies for exposing
individuals to ambient concentrations of PM
and improving dosimetric techniques in
animal exposure models.
Particulate Matter Center
Interactions
PM center personnel have met on an annual
basis since the inception of the centers. At the
ﬁrst PM center directors meeting, the directors
and their colleagues described the research
planned or under way within their respective
PM centers. This was a period of familiariza-
tion and was characterized by informative
reports. At the third meeting in Boston (July
2001), there was a sea change in the approach
of the PM centers to their mission. It became
apparent that there needed to be greater inter-
action across PM centers in an intellectual con-
text as well as greater collaboration in a wide
range of research areas. There was a clear need
expressed to communicate more effectively on
an ongoing basis and to interact with the U.S.
EPA in a collaborative context to assist in the
U.S. EPA research program more fully. 
Since July 2001, the PM center directors
and selected colleagues have held conference
calls on a regular basis to discuss directions in
research and collaborations. These discussions
have resulted in development of both short-
and long-term research goals, with intercenter
collaborations as an important mechanism in
achieving these goals. In this report, both short-
term and long-term research goals are described
for the PM centers overall and form the basis
for collaboration and interaction over a second
5-year period of funding. There are now plans
for a number of joint research efforts and work-
shops. The PM center directors believe that
funding of individual research grants should
continue through the STAR program and other
sources, e.g., NIEHS and HEI, and one chal-
lenge would be to find a way to link the
research of individual investigators and research
teams to the uniﬁed efforts of the PM centers.
We believe that a series of deﬁned workshops
organized by the PM centers would bring
together investigators from the PM centers and
the STAR program to discuss research ﬁndings
in the context of the U.S. EPA regulatory needs
and to seek out opportunities for further collab-
oration. This approach would be best organized
through a joint U.S. EPA-centers effort. The
ability to link a wide range of investigators from
around the country, both intellectually and
practically, represents a clear advantage of the
PM centers structure.
Particulate Matter Centers Research
and Its Implications for Public
Health and Regulatory Policy
Using complementary approaches, the centers
are addressing key policy issues such as
• What properties of PM are responsible for
health effects? This issue was identified by
the NRC committee as of critical impor-
tance. In testing hypotheses concerning PM
toxicity and attribution to specific con-
stituents or characteristics, work in the PM
centers is addressing particle mass versus
surface area versus number concentration
(ultrafines); the role of transition metals;
and the contributions to toxicity of acidity
versus organic compounds versus elemental
carbon. Toxicological approaches are
employing exposures to CAPs or laboratory-
generated PM in humans and animals; in
vitro approaches are using a number of cell
lines and specific particles; and epidemio-
logical studies are focusing on different PM
mixtures. This work should contribute not
only to our understanding of mechanisms of
response but also to development of more
targeted control strategies.
• Are there speciﬁc risk factors or effect modi-
ﬁers for PM effects? This is another high pri-
ority issue. Using a variety of approaches, PM
center programs are examining risk factors
such as age, gender, nutrition, and preexisting
cardiopulmonary disease. All of the PM cen-
ters are currently conducting work to identify
and characterize susceptible populations, a
clear prerequisite of any regulatory policy.
• What types of PM pose the greatest health
risks? What effects are directly attributable to
PM, and what health responses may be mod-
iﬁed by other air pollutants? These are areas
of intense research focus within the PM cen-
ters using the different research strengths
housed within each of them. It is the output
from these integrated programs that will help
set the next PM NAAQS and address issues
raised by the public, industry, government,
and public advisory bodies such as CASAC.
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